succinylcholine has been researched along with Anesthesia Related Hyperthermia in 311 studies
Succinylcholine: A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for.
succinylcholine : A quaternary ammonium ion that is the bis-choline ester of succinic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Succinylcholine causes immediate and severe arterial hypotension in swine with the malignant hyperthermia phenotype." | 7.70 | Malignant hyperthermia phenotype: hypotension induced by succinylcholine in susceptible swine. ( Iaizzo, PA; Sigg, DC, 2000) |
| "Neuroleptic malignant syndrome (NMS) and malignant hyperthermia (MH) may have a common pathogenic mechanism; therefore, it has been suggested that known triggering agents for MH (such as succinylcholine) should be avoided in patients with NMS." | 7.69 | Neuroleptic malignant syndrome and mivacurium: a safe alternative to succinylcholine? ( Brull, SJ; Kelly, D, 1994) |
| "Succinylcholine-induced masseter muscle rigidity (MMR) is a potentially life-threatening complication of anesthesia and is closely correlated with the heterogeneous disorder malignant hyperthermia (MH) susceptibility." | 7.69 | Masseter muscle rigidity associated with glycine1306-to-alanine mutation in the adult muscle sodium channel alpha-subunit gene. ( Fletcher, JE; George, AL; Heiman-Patterson, T; Jedlicka, AE; Levitt, RC; Olckers, A; Rosenberg, H; Vita, GM, 1995) |
| "We evaluated six boys who had developed isolated masseter muscle spasm following intravenous succinylcholine." | 7.66 | Masseter spasm induced by succinylcholine in children: contracture testing for malignant hyperthermia: report of six cases. ( Flewellen, EH; Nelson, TE, 1982) |
| " The literature is briefly reviewed and an account of the present status of malignant hyperthermia (porcine stress syndrome) in Ontario boars using the halothane or halothane/succinylcholine screening tests is presented." | 7.66 | Halothane and halothane/succinylcholine induced malignant hyperthermia (porcine stress syndrome) in a population of Ontario boars. ( Basrur, PK; McDonell, WN; Seeler, DC, 1983) |
| "Masseter muscle rigidity was defined clinically by the transient inability to distract the mandible from the maxilla such that the mouth could not be opened or could only be opened with force." | 5.29 | The incidence of masseter muscle rigidity after succinylcholine in infants and children. ( Burrows, FA; Carr, AS; Creighton, RE; Lazzell, VA; Lerman, J, 1994) |
| "This report describes a cardiac arrest that occurred in a 4-month-old infant during induction of anesthesia." | 5.28 | [Cardiac arrest during anesthesia induction with halothane and succinylcholine in an infant. Massive hyperkalemia and rhabdomyolysis in suspected myopathy and/or malignant hyperthermia]. ( Bachour, H; Mehler, J; Simons, F; Wolpers, K, 1991) |
| ", malignant hyperthermia and prolonged apnea after succinylcholine)." | 5.05 | Personalized pediatric anesthesia and pain management: problem-based review. ( Hendrickson, M; Horn, N; Packiasabapathy, S; Rangasamy, V; Renschler, J; Sadhasivam, S, 2020) |
| " The use of succinylcholine should be avoided in muscular dystrophies, motor neuron diseases, and intrinsic muscle disease due to a risk of malignant hyperthermia, hyperkalemia, rhabdomyolysis, and cardiac arrest." | 4.95 | Anesthetic consideration for neuromuscular diseases. ( Katz, JA; Murphy, GS, 2017) |
| "Anesthetic complications in patients with DMD and BD include intraoperative heart failure, inhaled anesthetic-related rhabdomyolysis (absence of succinylcholine), and succinylcholine-induced rhabdomyolysis and hyperkalemia." | 4.85 | Malignant hyperthermia and muscular dystrophies. ( Brown, A; Gurnaney, H; Litman, RS, 2009) |
| "The findings include the mechanisms of the hyperkalemia after succinylcholine in patients with upregulation of acetylcholine receptors." | 4.84 | Neuromuscular and mitochondrial disorders: what is relevant to the anaesthesiologist? ( Driessen, JJ, 2008) |
| " However, experts worldwide agree that the only reference test to this day remains the in vitro halothane caffeine contracture tests." | 4.77 | [Screening tests for malignant hyperthermia susceptibility]. ( Adnet, P; Krivosic-Horber, R, 1989) |
| "Malignant hyperthermia (MH) is a severe hypermetabolic disorder associated with dysregulation of calcium homeostasis and is triggered by inhalational anesthetics (isoflurane, sevoflurane, desflurane) and a depolarizing muscle relaxant (succinylcholine)." | 4.02 | Malignant hyperthermia in a 16-day-old infant with congenital diaphragmatic hernia: a case report. ( Kakuta, N; Kanzaki, R; Kawanishi, R; Kondo, T; Miyoshi, H; Morio, A; Mukaida, K; Noda, Y; Tanaka, K; Tsutsumi, YM, 2021) |
| " In 1960, animal studies reported a transient increase in plasma potassium; further experiments in 1969 clearly demonstrated succinylcholine-induced hyperkalemia in burn patients." | 3.91 | A Chronology for the Identification and Disclosure of Adverse Effects of Succinylcholine. ( Desai, MS; Huang, L; Sang, CN, 2019) |
| " They include: (1) How much dantrolene should be available in facilities where volatile agents are not available or administered, and succinylcholine is only stocked on site for emergency purposes? (2) What defines masseter muscle rigidity? What is its relationship to MH, and how should it be managed when it occurs? (3) What is the relationship between MH susceptibility and heat- or exercise-related rhabdomyolysis? (4) What evidence-based interventions should be recommended to alleviate hyperthermia associated with MH? (5) After treatment of acute MH, how much dantrolene should be administered and for how long? What criteria should be used to determine stopping treatment with dantrolene? (6) Can patients with a suspected personal or family history of MH be safely anesthetized before diagnostic testing? This report describes the consensus process and the outcomes for each of the foregoing unanswered clinical questions." | 3.91 | Consensus Statement of the Malignant Hyperthermia Association of the United States on Unresolved Clinical Questions Concerning the Management of Patients With Malignant Hyperthermia. ( Larach, MG; Litman, RS; Mayes, L; Shukry, M; Smith, VI; Theroux, MC; Watt, S; Wong, CA, 2019) |
| "We describe a child who developed a malignant hyperthermia-like syndrome after exposure to succinylcholine and halothane." | 3.75 | Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation. ( Hogan, KJ; Vladutiu, GD, 2009) |
| "Succinylcholine causes immediate and severe arterial hypotension in swine with the malignant hyperthermia phenotype." | 3.70 | Malignant hyperthermia phenotype: hypotension induced by succinylcholine in susceptible swine. ( Iaizzo, PA; Sigg, DC, 2000) |
| "Neuroleptic malignant syndrome (NMS) and malignant hyperthermia (MH) may have a common pathogenic mechanism; therefore, it has been suggested that known triggering agents for MH (such as succinylcholine) should be avoided in patients with NMS." | 3.69 | Neuroleptic malignant syndrome and mivacurium: a safe alternative to succinylcholine? ( Brull, SJ; Kelly, D, 1994) |
| "Succinylcholine-induced masseter muscle rigidity (MMR) is a potentially life-threatening complication of anesthesia and is closely correlated with the heterogeneous disorder malignant hyperthermia (MH) susceptibility." | 3.69 | Masseter muscle rigidity associated with glycine1306-to-alanine mutation in the adult muscle sodium channel alpha-subunit gene. ( Fletcher, JE; George, AL; Heiman-Patterson, T; Jedlicka, AE; Levitt, RC; Olckers, A; Rosenberg, H; Vita, GM, 1995) |
| "This retrospective study was undertaken to examine the management and outcome of children who developed isolated masseter muscle spasm (MMS) after the administration of intravenous succinylcholine during anesthetic induction." | 3.68 | Masseter muscle spasm in children: implications of continuing the triggering anesthetic. ( Bose, D; Cameron, CB; Littleford, JA; McKillop, C; Patel, LR, 1991) |
| "It has been claimed that the combination of halothane and succinylcholine, commonly used for anesthetic induction during short pediatric otolaryngologic procedures, is associated with a 1% incidence of masseter spasm (MS) which may be an early sign of malignant hyperthermia (MH)." | 3.68 | Masseter spasm and malignant hyperthermia: a retrospective review of a hospital-based pediatric otolaryngology practice. ( Brandom, BW; Chan, KH; Kosko, JR, 1992) |
| " Following an uneventful induction of anaesthesia with halothane, nitrous oxide and O2, succinylcholine resulted in bilateral masseter muscle spasm and then, in rapid sequence, ventricular tachycardia and cardiac arrest." | 3.67 | Duchenne muscular dystrophy and malignant hyperthermia--two case reports. ( Stanley, TH; Wang, JM, 1986) |
| "Seventy-seven patients who developed masseter muscle rigidity (MMR) after receiving succinylcholine to facilitate tracheal intubation were evaluated for malignant hyperthermia (MH) susceptibility by in vitro halothane and caffeine contracture tests." | 3.67 | Masseter muscle rigidity and malignant hyperthermia susceptibility. ( Fletcher, JE; Rosenberg, H, 1986) |
| " Succinylcholine administration caused prolonged, severe muscle fasciculations followed by tachycardia, and an elevated blood pressure." | 3.67 | Unusual response following use of succinylcholine in a horse anesthetized with halothane. ( Hildebrand, SV; Riedesel, DH, 1985) |
| "The authors examined the thesis that a dose of dantrolene producing 95 per cent of maximal muscle relaxation (ED95) would effectively prevent or treat malignant hyperthermia (MH)." | 3.66 | Dantrolene dose response in malignant hyperthermia-susceptible (MHS) swine: method to obtain prophylaxis and therapeusis. ( Flewellen, EH; Nelson, TE, 1980) |
| " A patient with strabismus (esotropia) had tachycardia and masseter muscle rigidity on exposure to succinylcholine chloride and halothane, but because of rapid recognition of the condition and discontinuation of the procedure, the potentially lethal complications of malignant hyperthermia did not develop." | 3.66 | Suspected malignant hyperthermia in a strabismus patient. A case report. ( Dodd, MJ; Phattiyakul, P; Silpasuvan, S, 1981) |
| " The literature is briefly reviewed and an account of the present status of malignant hyperthermia (porcine stress syndrome) in Ontario boars using the halothane or halothane/succinylcholine screening tests is presented." | 3.66 | Halothane and halothane/succinylcholine induced malignant hyperthermia (porcine stress syndrome) in a population of Ontario boars. ( Basrur, PK; McDonell, WN; Seeler, DC, 1983) |
| "We evaluated six boys who had developed isolated masseter muscle spasm following intravenous succinylcholine." | 3.66 | Masseter spasm induced by succinylcholine in children: contracture testing for malignant hyperthermia: report of six cases. ( Flewellen, EH; Nelson, TE, 1982) |
| " The treatment (ice packs, treatment of acidosis, glucose-insulin, methylprednisolone, lidocaine, verapamil, muscular relaxation and oxygen breathing) was effective." | 3.65 | [A further case of malignant hyperpyrexia and its treatment with lidocaine, methylprednisolone and verapamil (iproveratril) (author's transl)]. ( Bake, I; Buttazzoni, E; Csongrady, A; Pfänder, C; Schneider, M; Tarmann, H, 1976) |
| "Dantrolene was administered in 24 cases." | 3.01 | Malignant hyperthermia in maxillofacial surgery: Literature review supported by case presentation. ( Aires, CCG; Amorim, JA; Carneiro, SCAS; de Souza, RRL; Diniz, DA; Santos, FG; Vasconcellos, RJH, 2023) |
| "In particular, masseter spasm and dark urine were more common in the middle cohort when succinylcholine was administered (masseter spasm: versus youngest cohort, P = ." | 2.82 | Age-Specific Clinical Features of Pediatric Malignant Hyperthermia: A Review of 187 Cases Over 60 Years in Japan. ( Miyoshi, H; Mukaida, K; Nakamura, R; Otsuki, S; Tsutsumi, YM; Yasuda, T, 2022) |
| "MD is not at increased risk for malignant hyperthermia and should not be managed with prolonged propofol infusion." | 2.82 | Anesthetic Management of the Patient with Mitochondrial Disease: A Review of Current Best Evidence. ( Brody, KM, 2022) |
| "Individuals susceptible to malignant hyperpyrexia have muscle with heightened sensitivity to halothane, caffeine, succinylcholine, potassium chloride, and temperature change." | 2.64 | Identification of susceptibility to malignant hyperpyrexia. ( Denborough, MA; Moulds, RF, 1974) |
| "Succinylcholine was used in 46% (n = 710) of grade IV mask ventilation cases (median dose, 100 mg, 1." | 2.61 | Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic Review. ( Adelman, BT; Aziz, MF; Belani, KG; Berman, MF; Berris, J; Biggs, DA; Brandom, BW; Capacchione, J; Coffman, T; Coles, P; Craft, RM; Cummings, KC; Durieux, ME; Ellis, TA; Ginde, AA; Harris, JM; Helsten, DL; Herlich, A; Kheterpal, S; Kim, TW; Klumpner, TT; Kooij, F; LaGorio, J; Larach, MG; Limoncelli, J; Lins, S; Mackey, SC; Mashman, D; McCormick, PJ; Miller, SA; Molina, S; Nair, BJ; Nanamori, M; Neuman, MD; Pace, NL; Paganelli, WC; Peterson, W; Price, Z; Riazi, S; Schonberger, RB; Sivak, EL; Soto, R; Tom, S; Turnbull, ZA; van Klei, WA; Vaughn, MT; Wanderer, JP; Wedeven, C; Wilczak, J, 2019) |
| "In this article the pathophysiology of malignant hyperthermia, its signs, symptoms and treatment as well as safe anesthetic agents for individuals susceptible to malignant hyperthermia are discussed." | 2.42 | [Malignant hyperthermia]. ( Glahn, KP, 2003) |
| " The successful treatment is based on an early diagnosis, immediately interruption of triggering agents, intravenous administration of Dantrolene in sufficient dosage and starting of adequate symptomatic treatment." | 2.41 | [Malignant hyperthermia]. ( Ben Ammar, MS; Bouhajja, B; Haddad, F, 2002) |
| " Adverse effects of suxamethonium are generally related to its agonist mode of action." | 2.39 | Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management. ( Abel, M; Book, WJ; Eisenkraft, JB, 1994) |
| "A case of malignant hyperpyrexia (MH) occurring in a patient undergoing orthognathic surgery is reported which resulted in the procedure being abandoned prior to completion." | 2.39 | Malignant hyperpyrexia in oral surgery--case report and literature review. ( Hindle, I; Monaghan, A, 1994) |
| "Malignant hyperthermia is a potentially fatal disease that may be triggered by the administration of specific drugs or by stress." | 2.38 | Malignant hyperthermia and the general dentist: current recommendations. ( Haas, DA; Harper, DG; Young, ER, 1992) |
| "Masseter spasm is often associated with severe rhabdomyolysis in patients with muscle dystrophy, especially Duchenne's dystrophy." | 2.38 | [Clinical features of malignant hyperthermia crisis]. ( Cornet, C; Laxenaire, MC; Moeller, R, 1989) |
| "This contracture is not prevented or relieved by regional anaesthesia or muscle relaxants." | 2.38 | [Anesthesia in myotonia]. ( Lienhart, A, 1989) |
| "This report reviews what is known about malignant hyperthermia and proposes a course of action when the syndrome occurs in a patient undergoing ECT or a patient with known susceptibility to malignant hyperthermia needs ECT." | 2.37 | Malignant hyperthermia and ECT. ( Morrow, DH; Yacoub, OF, 1986) |
| "Malignant hyperthermia was suspected and the treatment was started, but he developed cardiopulmonary arrest and died an hour and a half after the first cardiac arrest." | 1.72 | Spinal cord injury-related thermoregulatory impairment masks a fatal malignant hyperthermia crisis: a case report. ( Alves, JFF; Amaral, JLG; Andrade, PV; Lutke, C; Santos, JM; Silva, HCA; Souza, LS; Vainzof, M, 2022) |
| "The diagnosis of malignant hyperthermia (MH) susceptibility could be confirmed in the patient 4 months after the acute event by the in vitro contracture test and detection of the MH causative mutation p." | 1.48 | [Abortive course of malignant hyperthermia following preclinical induction of general anesthesia using succinylcholine]. ( Helf, D; Johannsen, S; Markus, CK; Schneiderbanger, D; Schuster, F, 2018) |
| "Type A aortic dissections are surgical emergencies requiring cardiopulmonary bypass and frequently deep hypothermic circulatory arrest." | 1.46 | Suspected Malignant Hyperthermia in the Setting of Hypothermic Circulatory Arrest for Type A Aortic Dissection Repair: A Case Report. ( Bunting, B; Knight, J; McHugh, SM, 2017) |
| "Sporadic clinical episodes of malignant hyperthermia (MH) that develop during general anaesthesia (GA) have been reported in Singapore." | 1.46 | Malignant Hyperthermia and Ryanodine Receptor Type 1 Gene (RyR1) Mutation in a Family in Singapore. ( Lai, PS; Lee, DW; Lee, TL; Li, DW; Yong, RY, 2017) |
| "The more insidious character of malignant hyperthermia is most likely due to the lower triggering potency of modern volatile anaesthetics, the mitigating effects of several intravenous drugs (neuromuscular blocking agents, alpha 2 adrenergic receptor agonists, beta adrenergic blockade) or techniques (neuraxial anaesthesia) and the routine use of end-tidal CO2 monitoring leading to the early withdrawal of triggering drugs." | 1.42 | The changing face of malignant hyperthermia: less fulminant, more insidious.. ( Forget, P; Heytens, L; Scholtès, JL; Veyckemans, F, 2015) |
| "If succinylcholine was not given, MH onset was shorter during sevoflurane anesthesia than during desflurane or isoflurane." | 1.40 | Anesthetic drugs and onset of malignant hyperthermia. ( Brandom, BW; Visoiu, M; Wieland, K; Young, MC, 2014) |
| "This report describes an episode of malignant hyperthermia (MH) in a 53-year-old Japanese man during general anesthesia that was triggered by isoflurane and succinylcholine." | 1.37 | Ring fibers visualized by electron microscopy in a Japanese patient with malignant hyperthermia. ( Hashimoto, K; Kitagawa, Y; Kuriyama, M; Sano, K; Sato, J, 2011) |
| "Succinylcholine has been identified as the trigger agent, as other possible trigger agents were not involved." | 1.33 | Malignant hyperthermia: a case report in Thai Anesthesia Incidents Study (THAI Study). ( Charuluxananan, S; Inphum, P; Kitsampanwong, W; Pulnitiporn, A, 2005) |
| "A 38-year-old man diagnosed as esophageal achalasia developed masseter muscle rigidity after intravenous suxamethonium during anesthetic induction." | 1.32 | [Masseter muscle rigidity after suxamethonium during induction and postoperative abortive malignant hyperthermia in a patient with esophageal achalasia]. ( Anzai, T; Arakawa, Y; Hoka, S; Kanai, A; Kuroiwa, M; Okamoto, H, 2004) |
| "A case of malignant hyperthermia (mh) in a 27-year-old man is described." | 1.31 | Fatal malignant hyperthermia--delayed onset and atypical course. ( Karger, B; Teige, K, 2002) |
| "A positive DNA test indicates malignant hyperthermia susceptibility with "causative" mutations but discordance requires that negative DNA tests are confirmed with in vitro contracture test." | 1.31 | Suspected malignant hyperthermia reactions in New Zealand. ( Couchman, K; Langton, EE; Pollock, AN; Stowell, KM; Waddington, M, 2002) |
| "Sevoflurane was discontinued and dantrolene was given by intravenous bolus." | 1.31 | Malignant hyperthermia in a patient with Graves' disease during subtotal thyroidectomy. ( Genma, R; Kitahara, A; Matsushita, A; Nakamura, H; Nakano, K; Natsume, H; Nishiyama, K; Sasaki, S; Yamamoto, Y, 2001) |
| "About 50% of malignant hyperthermia patients carry a mutation in the RYR1 gene." | 1.31 | Suxamethonium-induced rhabdomyolysis in a healthy middle-aged man. ( Annila, P; Koivisto, P; Le Puura, AI, 2000) |
| "Because malignant hyperthermia (MH) was suspected, he was treated with dantrolene, fluid loading, and continuous hemodiafiltration along with symptomatic supportive care." | 1.30 | Malignant hyperthermia induced by general anesthesia for bone marrow harvesting. ( Akazawa, H; Hirai, H; Hoshide, S; Hosoya, N; Kanda, Y; Maekawa, K; Mimura, T; Miyagawa, K; Takahashi, N; Yazaki, Y, 1997) |
| "In 1992, the Malignant Hyperthermia Association of the United States and The North American Malignant Hyperthermia Registry received reports of cardiac arrest in apparently healthy children given succinylcholine." | 1.30 | Hyperkalemic cardiac arrest during anesthesia in infants and children with occult myopathies. ( Allen, GC; Gronert, GA; Larach, MG; Rosenberg, H, 1997) |
| "To investigate a possible link of malignant hyperthermia to capture myopathy, between June 1990 and July 1993 we anesthetized four black-tailed deer (Odocoileus hemionus columbianus) and challenged them with halothane and succinylcholine." | 1.29 | Evaluation for malignant hyperthermia susceptibility in black-tailed deer. ( Antognini, JF; Eisele, PH; Gronert, GA, 1996) |
| "Masseter muscle rigidity was defined clinically by the transient inability to distract the mandible from the maxilla such that the mouth could not be opened or could only be opened with force." | 1.29 | The incidence of masseter muscle rigidity after succinylcholine in infants and children. ( Burrows, FA; Carr, AS; Creighton, RE; Lazzell, VA; Lerman, J, 1994) |
| "We experienced a case of abortive malignant hyperthermia during funnel chest surgery." | 1.29 | [A case of abortive malignant hyperthermia during funnel chest surgery]. ( Enzan, K; Komatsu, H; Suzuki, M, 1993) |
| "Subsequent testing for susceptibility to malignant hyperthermia proved positive for the patient and four other members of the family." | 1.29 | Serum and urinary myoglobin following an aborted malignant hyperthermia reaction. ( Collins, W; Hopkins, PM; Laurence, AS; Vanner, GK, 1996) |
| "An acute episode of a malignant hyperthermia-like syndrome is described which occurred after suxamethonium and isoflurane anaesthesia in a 41-year-old healthy male patient undergoing a minor elective hand operation." | 1.28 | A case of malignant hyperthermia? ( Boersma, GA; Broekema, AA; Hennis, PJ, 1991) |
| "Pretreatment with diltiazem modified an MH response." | 1.28 | Effect of diltiazem on porcine malignant hyperpyrexia induced by suxamethonium and halothane. ( Denborough, MA; Foster, PS; Hopkinson, KC, 1989) |
| "Based on studies in swine, the malignant hyperthermia syndrome has been postulated to result from an enhanced sensitivity (low threshold) of the Ca2(+)-induced Ca2(+)-release process." | 1.28 | Fatty acids modulate calcium-induced calcium release from skeletal muscle heavy sarcoplasmic reticulum fractions: implications for malignant hyperthermia. ( Beech, J; Conti, PA; Erwin, K; Fletcher, JE; Hanson, S; Rosenberg, H; Tripolitis, L, 1990) |
| "To determine whether a malignant hyperthermia (MH) episode could nevertheless be provoked by a more rigorous challenge, both genetically MHS (Pietrain) and normal (Yorkshire) 5-wk-old piglets were exposed to a combined halothane-succinylcholine challenge." | 1.28 | Halothane sensitivity of young pigs in vivo and in vitro. ( Fay, RS; Gallant, EM, 1990) |
| "This report describes a cardiac arrest that occurred in a 4-month-old infant during induction of anesthesia." | 1.28 | [Cardiac arrest during anesthesia induction with halothane and succinylcholine in an infant. Massive hyperkalemia and rhabdomyolysis in suspected myopathy and/or malignant hyperthermia]. ( Bachour, H; Mehler, J; Simons, F; Wolpers, K, 1991) |
| "Three cases of muscular dystrophy are reported on (8 years, 4 months, 10 months) in which serious conditions arose under anaesthetic (bradycardia, asystolia, hyperkalemia, rising CPK)." | 1.28 | [Muscular dystrophy as a risk factor in anesthesia]. ( Eyrich, K; Schneider, V; Stelzner, J, 1992) |
| "Succinylcholine was administered by infusion to halothane-anesthetized ponies to determine dosage requirements for surgical relaxation up to 3 hours' duration." | 1.27 | Succinylcholine infusion associated with hyperthermia in ponies anesthetized with halothane. ( Hildebrand, SV; Howitt, GA, 1983) |
| "There was no evidence of malignant hyperthermia (MH) in patients receiving succinylcholine, suggesting that an association between NMS and MH may not be clinically relevant in patients being treated with ECT." | 1.27 | ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome. ( Addonizio, G; Susman, VL, 1987) |
| "Malignant hyperthermia is a seemingly rare genetic myopathy." | 1.27 | Malignant hyperthermia in plastic surgery. ( Abdul-Rasool, IH; Dubrow, TJ; Lesavoy, MA; Wackym, PA, 1988) |
| "Dantrolene was only used in 32% of cases, and then at inadequate doses and very often too late; this probably explains the large number of treatment failures." | 1.27 | [Registration of peranesthetic cases of malignant hyperthermia in France. An update]. ( Jacquot, C; Kozak-Reiss, G; Krivosic-Horber, R; Laxenaire, MC; Lienhart, A; Nivoche, Y; Stieglitz, P, 1988) |
| "We report a case of induction trismus and discuss its association with malignant hyperthermia." | 1.27 | Anesthetic induction trismus, more than a closed-mouth problem. ( Belman, AB; Skoog, SJ, 1986) |
| "in an attempt to induce malignant hyperthermia." | 1.27 | Failure to induce malignant hyperthermia in myotonic goats. ( Gronert, GA; Lambert, EH; Newberg, LA, 1983) |
| "The familial nature of anaesthetic malignant hyperthermia must lead to the search for susceptibility in other members of the family of a sensitive subject." | 1.27 | [Examination of the family of a patient susceptible to anesthetic malignant hyperthermia]. ( Adnet, P; Guévart, E; Krivosic, I; Krivosic-Horber, R; Theunynck, D, 1986) |
| "The susceptibility of these animals to malignant hyperthermia or the porcine stress syndrome was unknown at the time of the study." | 1.27 | Evaluation of a commercial creatine kinase screening test for malignant hyperthermia (porcine stress syndrome). ( Basrur, PK; McDonell, WN; Seeler, DC, 1986) |
| "King's syndrome is a sporadic genetic syndrome exhibiting characteristic facial features, short stature, and subclinical myopathy." | 1.27 | King's syndrome with malignant hyperthermia. Potential outpatient risks. ( Steenson, AJ; Torkelson, RD, 1987) |
| "All cases of suspected malignant hyperthermia forwarded to the Danish Malignant Hyperthermia Register during a 6." | 1.27 | Incidence of malignant hyperthermia in Denmark. ( Ording, H, 1985) |
| "In five of the children, cardiac arrest occurred despite apparently adequate respiratory support." | 1.27 | Anaesthesia and progressive muscular dystrophy. ( Bush, GH; Smith, CL, 1985) |
| "When muscle spasm is induced with suxamethonium, malignant hyperpyrexia must be considered a probable diagnosis." | 1.27 | Suxamethonium spasm. A differential diagnostic conundrum. ( Ellis, FR; Halsall, PJ, 1984) |
| "The true incidence of malignant hyperthermia is unknown, but the frequency has been estimated as high as 1/14,000 anesthetic events." | 1.26 | Malignant hyperthermia. ( Nissen, RL; Yonkers, AJ, 1982) |
| "This situation may be similar to that in malignant hyperpyrexia (MH) occurring in mammals." | 1.26 | The chick as a model for malignant hyperpyrexia. ( Korczyn, AD; Shavit, S; Shlosberg, I, 1980) |
| "In this Research Conference we define malignant hyperthermia, present its brief history, and describe the diagnostic procedures and directions of research in our laboratory." | 1.26 | Malignant hyperthermia: diagnosis, treatment and investigations of a skeletal muscle lesion. ( Flewellen, EH; Nelson, TE, 1979) |
| "A case of malignant hyperthermia with muscle stiffness is described." | 1.26 | [Malignant hyperthermia. Report on a case successfully treated by procaine infusion (author's transl)]. ( Bentia, L; Ghiga, R; Litarczek, G, 1978) |
| "During malignant hyperthermia (MH) induced by halothane and succinylcholine, oxygen consumption (VO2) of whole body, muscle and the splanchnic area was calculated from measurements of blood flow and arteriovenous oxygen content difference." | 1.26 | Porcine malignant hyperthermia: role of skeletal muscle in increased oxygen consumption. ( Gronert, GA; Heffron, JJ; Milde, JH; Theye, RA, 1977) |
| "Two cases of malignant hyperthermia with different clinical courses are reported." | 1.26 | [Report on 2 cases of malignant hyperthermia with different clinical courses]. ( Freiberger, K; Gullotta, F; Helpap, B; Menzel, H, 1976) |
| "In addition to two published cases of malignant hyperthermia (M." | 1.26 | [Mild form of malignant hyperthermia? OR, ABNORMAL REACTION To succinyldicholine?]. ( Hammami, G; Sajons, M; Zinganell, K, 1976) |
| "Experience with eight cases of malignant hyperpyrexia are presented." | 1.26 | Clinical management of malignant hyperpyrexia. ( Krasna, IH; Sonnenklar, N, 1976) |
| "Fever may be a late manifestation of the malignant hyperpyrexia syndrome, and it is important to be aware of the early signs." | 1.26 | Malignant hyperpyrexia during anesthesia in childhood. ( Bloom, DA; Fonkalsrud, EW; Reynolds, RC, 1976) |
| "An exceptionally serious case of malignant hyperthermia in a 17 year old male is presented." | 1.26 | [Malignant hyperthermia. A case report (author's transl)]. ( Rettig, B; Weitz, H, 1980) |
| "When dantrolene was added to supportive therapy, Vo2, lactate, K+, catecholamines, and temperature decreased, and the course of MH was dramatically slowed and, apparently, reversed." | 1.26 | Dantrolene in porcine malignant hyperthermia. ( Gronert, GA; Milde, JH; Theye, RA, 1976) |
| "Porcine malignant hyperthermia was studied in seven Pietrain pigs under standardized experimental conditions." | 1.26 | Porcine malignant hyperthermia. I: Metabolic and physiological changes. ( Hall, GM; Lister, D; Lucke, JN, 1976) |
| "Since it is known that malignant hyperthermia has a familial predilection, it seems very important that clinical, biochemical, and morphological investigations be performed such as CPK estimations and muscular biopsies not only of the patients but also of the relatives in order to rule out this type of latent myopathy." | 1.25 | [Histological, histochemical, and ultrastructural findings in malignant hyperthermia (author's transl)]. ( Gullotta, F; Helpap, B, 1975) |
| "A case of malignant hyperpyrexia with unusual features in a South African negro child is described." | 1.25 | An unusual case of malignant hyperpyrexia. First reported case in a South African negro. ( Carstens, J; Peltz, B, 1975) |
| "The methods used to screen patients for malignant hyperpyrexia at present are not sufficiently accurate." | 1.25 | Screening for malignant hyperpyrexia. ( Ellis, FR; Hargreaves, JB; Harriman, DG; Keaney, NP; Kyei-Mensah, K; Mulrooney, PL; Parikh, RK; Sumner, DW; Tyrrell, JH, 1972) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 172 (55.31) | 18.7374 |
| 1990's | 60 (19.29) | 18.2507 |
| 2000's | 28 (9.00) | 29.6817 |
| 2010's | 37 (11.90) | 24.3611 |
| 2020's | 14 (4.50) | 2.80 |
| Authors | Studies |
|---|---|
| Andrade, PV | 1 |
| Souza, LS | 1 |
| Santos, JM | 1 |
| Alves, JFF | 1 |
| Lutke, C | 1 |
| Amaral, JLG | 1 |
| Vainzof, M | 1 |
| Silva, HCA | 1 |
| Otsuki, S | 1 |
| Miyoshi, H | 2 |
| Mukaida, K | 4 |
| Yasuda, T | 1 |
| Nakamura, R | 1 |
| Tsutsumi, YM | 2 |
| Brody, KM | 1 |
| Cieniewicz, A | 1 |
| Trzebicki, J | 1 |
| Aires, CCG | 1 |
| de Souza, RRL | 1 |
| Amorim, JA | 1 |
| Santos, FG | 1 |
| Diniz, DA | 1 |
| Carneiro, SCAS | 1 |
| Vasconcellos, RJH | 1 |
| Riazi, S | 4 |
| Bersselaar, LRVD | 1 |
| Islander, G | 1 |
| Heytens, L | 2 |
| Snoeck, MMJ | 1 |
| Bjorksten, A | 1 |
| Gillies, R | 1 |
| Dranitsaris, G | 1 |
| Hellblom, A | 1 |
| Treves, S | 2 |
| Kunst, G | 1 |
| Voermans, NC | 1 |
| Jungbluth, H | 1 |
| Blais, A | 1 |
| Rodrigues, G | 1 |
| de Andrade, PV | 1 |
| Dos Santos, JM | 1 |
| do Amaral, JLG | 1 |
| da Silva, HCA | 1 |
| Floridis, J | 1 |
| Barbour, R | 1 |
| Fu, PH | 1 |
| Ho, CN | 1 |
| Larach, MG | 6 |
| Klumpner, TT | 2 |
| Brandom, BW | 7 |
| Vaughn, MT | 2 |
| Belani, KG | 5 |
| Herlich, A | 2 |
| Kim, TW | 2 |
| Limoncelli, J | 2 |
| Sivak, EL | 2 |
| Capacchione, J | 2 |
| Mashman, D | 2 |
| Johannsen, S | 6 |
| Schuster, F | 8 |
| Huang, L | 1 |
| Sang, CN | 1 |
| Desai, MS | 2 |
| Packiasabapathy, S | 1 |
| Rangasamy, V | 1 |
| Horn, N | 1 |
| Hendrickson, M | 1 |
| Renschler, J | 1 |
| Sadhasivam, S | 1 |
| Baye, JF | 1 |
| Petry, NJ | 1 |
| Jacobson, SL | 1 |
| Moore, MM | 1 |
| Tucker, B | 1 |
| Shaaban, S | 1 |
| Massmann, AK | 1 |
| Clark, NM | 1 |
| Schultz, AJ | 1 |
| Kakuta, N | 1 |
| Kawanishi, R | 1 |
| Tanaka, K | 1 |
| Kanzaki, R | 1 |
| Morio, A | 1 |
| Noda, Y | 1 |
| Kondo, T | 1 |
| Otta, JJ | 1 |
| Ohden, L | 1 |
| Bell, DG | 1 |
| Katz, JA | 1 |
| Murphy, GS | 1 |
| Lu, Z | 1 |
| Rosenberg, H | 26 |
| Li, G | 1 |
| Li, DW | 1 |
| Lai, PS | 1 |
| Lee, DW | 1 |
| Yong, RY | 1 |
| Lee, TL | 1 |
| Helf, D | 1 |
| Schneiderbanger, D | 1 |
| Markus, CK | 1 |
| Gonsalves, SG | 1 |
| Dirksen, RT | 1 |
| Sangkuhl, K | 1 |
| Pulk, R | 1 |
| Alvarellos, M | 1 |
| Vo, T | 1 |
| Hikino, K | 1 |
| Roden, D | 1 |
| Klein, TE | 2 |
| Poler, SM | 1 |
| Patel, S | 2 |
| Caudle, KE | 1 |
| Gordon, R | 1 |
| Brandom, B | 1 |
| Biesecker, LG | 1 |
| Hopkins, PM | 5 |
| Kheterpal, S | 1 |
| Kooij, F | 1 |
| Wilczak, J | 1 |
| Soto, R | 1 |
| Berris, J | 1 |
| Price, Z | 1 |
| Lins, S | 1 |
| Coles, P | 1 |
| Harris, JM | 1 |
| Cummings, KC | 1 |
| Berman, MF | 1 |
| Nanamori, M | 1 |
| Adelman, BT | 1 |
| Wedeven, C | 1 |
| LaGorio, J | 1 |
| McCormick, PJ | 1 |
| Tom, S | 1 |
| Aziz, MF | 1 |
| Coffman, T | 1 |
| Ellis, TA | 1 |
| Molina, S | 1 |
| Peterson, W | 1 |
| Mackey, SC | 1 |
| van Klei, WA | 1 |
| Ginde, AA | 1 |
| Biggs, DA | 1 |
| Neuman, MD | 1 |
| Craft, RM | 1 |
| Pace, NL | 1 |
| Paganelli, WC | 1 |
| Durieux, ME | 1 |
| Nair, BJ | 1 |
| Wanderer, JP | 1 |
| Miller, SA | 1 |
| Helsten, DL | 1 |
| Turnbull, ZA | 1 |
| Schonberger, RB | 1 |
| Rosen, GP | 1 |
| Escobar, M | 1 |
| Fumero, P | 1 |
| Viswanath, O | 1 |
| Wright, J | 1 |
| Litman, RS | 3 |
| Smith, VI | 1 |
| Mayes, L | 1 |
| Shukry, M | 1 |
| Theroux, MC | 1 |
| Watt, S | 1 |
| Wong, CA | 1 |
| Brown, TC | 1 |
| Roewer, N | 6 |
| Hu, C | 1 |
| Wijeysundera, D | 1 |
| Massey, C | 1 |
| Kraeva, N | 1 |
| Muldoon, SM | 3 |
| Klingler, W | 1 |
| Heiderich, S | 1 |
| Girard, T | 2 |
| Gravino, E | 1 |
| Heffron, JJ | 3 |
| Jurkat-Rott, K | 1 |
| Rüffert, H | 1 |
| Snoeck, M | 2 |
| Sorrentino, V | 1 |
| Tegazzin, V | 3 |
| Lehmann-Horn, F | 2 |
| Visoiu, M | 1 |
| Young, MC | 1 |
| Wieland, K | 1 |
| Moegele, S | 1 |
| Metterlein, T | 3 |
| Anetseder, M | 3 |
| Jones, R | 1 |
| Shahid, F | 1 |
| Cowell, RP | 1 |
| Forget, P | 1 |
| Scholtès, JL | 1 |
| Veyckemans, F | 1 |
| Alvarellos, ML | 1 |
| McDonagh, EM | 1 |
| McLeod, HL | 1 |
| Altman, RB | 1 |
| Joshi, GP | 1 |
| Gayer, S | 1 |
| Vila, H | 1 |
| Bunting, B | 1 |
| Knight, J | 1 |
| McHugh, SM | 1 |
| Driessen, J | 1 |
| Kim, JH | 1 |
| Schwinn, DA | 1 |
| Landau, R | 1 |
| Rawicz, M | 1 |
| Wolf, A | 1 |
| Gurnaney, H | 1 |
| Brown, A | 1 |
| Hogan, KJ | 1 |
| Vladutiu, GD | 1 |
| Greenwood, M | 1 |
| Meechan, JG | 1 |
| Corvetto, MA | 1 |
| Taekman, JM | 1 |
| Kitagawa, Y | 1 |
| Sato, J | 1 |
| Kuriyama, M | 1 |
| Sano, K | 1 |
| Hashimoto, K | 1 |
| Kranke, P | 1 |
| Hager, M | 1 |
| Palmer, E | 1 |
| Block, FE | 1 |
| Migita, T | 1 |
| Kobayashi, M | 1 |
| Hamada, H | 1 |
| Kawamoto, M | 1 |
| Dexter, F | 1 |
| Epstein, RH | 1 |
| Wachtel, RE | 1 |
| Lavezzi, WA | 1 |
| Capacchione, JF | 1 |
| Sambuughin, N | 1 |
| Bina, S | 1 |
| Steele, D | 1 |
| Natasa, N | 1 |
| Snezana, P | 1 |
| Nemanja, Z | 1 |
| Zoran, K | 1 |
| Durasić, L | 1 |
| Claxton, BA | 1 |
| Cross, MH | 1 |
| Pollock, AN | 1 |
| Langton, EE | 1 |
| Couchman, K | 1 |
| Stowell, KM | 1 |
| Waddington, M | 1 |
| Karger, B | 1 |
| Teige, K | 1 |
| Bouhajja, B | 1 |
| Haddad, F | 1 |
| Ben Ammar, MS | 1 |
| Glahn, KP | 1 |
| Shigematsu, K | 1 |
| Shono, S | 1 |
| Tanigawa, K | 1 |
| Katori, K | 1 |
| Hamada, T | 1 |
| Higa, K | 1 |
| Collins, CP | 1 |
| Beirne, OR | 1 |
| Arakawa, Y | 1 |
| Kuroiwa, M | 1 |
| Anzai, T | 1 |
| Kanai, A | 1 |
| Okamoto, H | 1 |
| Hoka, S | 1 |
| Swan, H | 1 |
| Laitinen, PJ | 1 |
| Toivonen, L | 1 |
| Maghsoudi, B | 1 |
| Khademi, B | 1 |
| Pulnitiporn, A | 1 |
| Charuluxananan, S | 1 |
| Inphum, P | 1 |
| Kitsampanwong, W | 1 |
| Flick, RP | 1 |
| Gleich, SJ | 1 |
| Herr, MM | 1 |
| Wedel, DJ | 2 |
| Davis, M | 1 |
| James, D | 1 |
| Pollock, N | 1 |
| Stowell, K | 1 |
| Driessen, JJ | 1 |
| Azar, I | 1 |
| Di Prospero, S | 1 |
| Bianchi, S | 1 |
| Di Lazzaro, M | 1 |
| Camilli-Giammei, T | 1 |
| Nissen, RL | 1 |
| Yonkers, AJ | 1 |
| Viby-Mogensen, J | 1 |
| Byrd, JP | 1 |
| Mori, K | 1 |
| Shingu, K | 1 |
| Antel, JP | 1 |
| Arnason, BG | 1 |
| Iwatsuki, N | 1 |
| Koga, Y | 1 |
| Amaha, K | 1 |
| Schwartz, L | 1 |
| Rockoff, MA | 1 |
| Koka, BV | 1 |
| Eng, GD | 1 |
| Becker, MJ | 1 |
| Haber, J | 1 |
| Hammer, DJ | 1 |
| Butler, B | 1 |
| Seeler, DC | 2 |
| McDonell, WN | 2 |
| Basrur, PK | 2 |
| Hildebrand, SV | 2 |
| Howitt, GA | 1 |
| Ellis, FR | 4 |
| Halsall, PJ | 2 |
| Flewellen, EH | 4 |
| Nelson, TE | 7 |
| Mitchell, G | 1 |
| Newberg, LA | 1 |
| Lambert, EH | 1 |
| Gronert, GA | 12 |
| Johnson, GC | 1 |
| Santos, AB | 1 |
| Matsubara, I | 1 |
| Sumiya, T | 1 |
| Yoshimura, T | 1 |
| Yamazaki, R | 1 |
| Kubota, M | 1 |
| Goto, Y | 1 |
| Fernsebner, B | 1 |
| Gallant, EM | 4 |
| Godt, RE | 1 |
| Hall, GM | 8 |
| Lucke, JN | 8 |
| Lister, D | 9 |
| Whittaker, M | 2 |
| Gohil, P | 1 |
| Forman, WM | 1 |
| Boheler, J | 1 |
| Hamrick, JC | 1 |
| McKnight, RL | 1 |
| Eger, EI | 1 |
| Muteki, T | 1 |
| Tokutomi, Y | 1 |
| Ueda, N | 1 |
| Nakamura, Y | 1 |
| Matsuoka, H | 1 |
| Iwai, Y | 1 |
| Yoshitake, K | 1 |
| Tsuda, H | 1 |
| Dodd, MJ | 1 |
| Phattiyakul, P | 1 |
| Silpasuvan, S | 1 |
| Lewandowski, KB | 1 |
| Schuh, FT | 1 |
| Sullivan, JS | 1 |
| Denborough, MA | 8 |
| Korczyn, AD | 1 |
| Shavit, S | 1 |
| Shlosberg, I | 1 |
| Shinohara, S | 1 |
| Toyosaki, M | 1 |
| Takata, K | 1 |
| Tanaka, S | 1 |
| Nagaoka, I | 1 |
| Iasa, M | 1 |
| Kawai, H | 2 |
| Rettig, B | 1 |
| Weitz, H | 1 |
| Plötz, J | 2 |
| Braun, J | 1 |
| Gericke, B | 1 |
| Melvoll, R | 1 |
| Stovner, J | 1 |
| Fairhurst, AS | 1 |
| Hamamoto, V | 1 |
| Macri, J | 1 |
| Inagaki, M | 1 |
| Koyama, A | 1 |
| Sakata, S | 1 |
| Tonogai, R | 1 |
| Yamada, Y | 1 |
| Iwasa, M | 1 |
| Kondo, A | 1 |
| Miyoshi, K | 1 |
| Dziadzka, A | 1 |
| Greim, CA | 1 |
| Kraas, E | 1 |
| Schulte am Esch, J | 2 |
| Fletcher, JE | 13 |
| Iaizzo, PA | 6 |
| Vita, GM | 1 |
| Olckers, A | 1 |
| Jedlicka, AE | 1 |
| George, AL | 1 |
| Heiman-Patterson, T | 2 |
| Levitt, RC | 1 |
| Petersen, WC | 1 |
| Crouch, ER | 1 |
| Bevan, DR | 1 |
| Kelly, D | 1 |
| Brull, SJ | 1 |
| Book, WJ | 1 |
| Abel, M | 1 |
| Eisenkraft, JB | 1 |
| Monaghan, A | 1 |
| Hindle, I | 1 |
| Lazzell, VA | 1 |
| Carr, AS | 1 |
| Lerman, J | 1 |
| Burrows, FA | 1 |
| Creighton, RE | 1 |
| Acquarone, N | 1 |
| Garibotto, G | 1 |
| Sofia, A | 1 |
| Gurreri, G | 1 |
| Stemp, LI | 1 |
| Komatsu, H | 1 |
| Enzan, K | 1 |
| Suzuki, M | 1 |
| Calvo, PA | 1 |
| Fernández-García, V | 1 |
| Bermejo, MA | 1 |
| Vázquez, C | 1 |
| Pereda, MJ | 1 |
| Altarriba, JM | 1 |
| Alvarez, E | 1 |
| Kehler, CH | 2 |
| Zink, RS | 1 |
| Sessler, DI | 2 |
| Carr, RJ | 1 |
| Scutari, E | 1 |
| Zorzato, F | 1 |
| Muiños, PA | 1 |
| Ortells, MA | 1 |
| Sánchez, G | 1 |
| Carrasco, MS | 1 |
| Shutack, JG | 1 |
| Herrero, E | 1 |
| Casinello, F | 1 |
| de Stefano, J | 1 |
| Fernández-Guisasola, J | 1 |
| Pérez-Gallardo, A | 1 |
| Habre, W | 1 |
| Sims, C | 1 |
| Laurence, AS | 2 |
| Vanner, GK | 1 |
| Collins, W | 1 |
| Allen, GC | 2 |
| Hosoya, N | 1 |
| Miyagawa, K | 1 |
| Mimura, T | 1 |
| Hoshide, S | 1 |
| Akazawa, H | 1 |
| Kanda, Y | 1 |
| Takahashi, N | 1 |
| Hirai, H | 1 |
| Maekawa, K | 1 |
| Yazaki, Y | 1 |
| Shi, Y | 1 |
| Storella, RJ | 1 |
| Keykhah, MM | 1 |
| Baraka, A | 1 |
| Antognini, JF | 1 |
| Eisele, PH | 2 |
| Brubaker, CL | 1 |
| Ramirez, JA | 1 |
| Cheetham, ED | 1 |
| Mills, P | 1 |
| Garrido, S | 1 |
| Fraga, M | 1 |
| Martín, MJ | 1 |
| Belda, J | 1 |
| Khalil, SN | 1 |
| Youngblood, B | 1 |
| Campos, C | 1 |
| Teichgraeber, JF | 1 |
| Goresky, GV | 1 |
| Cox, RG | 1 |
| Musley, SK | 1 |
| Beebe, DS | 1 |
| Komanduri, V | 1 |
| Le Puura, AI | 1 |
| Koivisto, P | 1 |
| Annila, P | 1 |
| Sigg, DC | 1 |
| Husová, L | 1 |
| Lata, J | 1 |
| Husa, P | 1 |
| O'Brien, B | 1 |
| Kamaraj, T | 1 |
| Ormonde, G | 1 |
| Adnet, P | 4 |
| Lacombe, DM | 1 |
| Kadar, AG | 1 |
| Kramer, BA | 1 |
| Barth, MC | 1 |
| White, PF | 1 |
| Nishiyama, K | 1 |
| Kitahara, A | 1 |
| Natsume, H | 1 |
| Matsushita, A | 1 |
| Nakano, K | 1 |
| Sasaki, S | 1 |
| Genma, R | 1 |
| Yamamoto, Y | 1 |
| Nakamura, H | 1 |
| Roberts, MC | 1 |
| Mickelson, JR | 2 |
| Patterson, EE | 1 |
| Armstrong, PJ | 1 |
| Brunson, DB | 1 |
| Hogan, K | 1 |
| Milde, JH | 3 |
| Theye, RA | 4 |
| Tsang, HS | 1 |
| Schoenfeld, FG | 1 |
| Moulds, RF | 4 |
| Bolis, GB | 1 |
| Bolis Ferranti, MG | 1 |
| Okumura, F | 1 |
| Crocker, BD | 1 |
| Steward, DJ | 1 |
| Kalow, W | 2 |
| Britt, BA | 2 |
| Richter, A | 1 |
| Bagshaw, RJ | 1 |
| Cox, RH | 1 |
| Knight, DH | 1 |
| Detweiler, DK | 1 |
| Gibbs, JM | 1 |
| Litarczek, G | 1 |
| Bentia, L | 1 |
| Ghiga, R | 1 |
| Goudsouzian, NG | 1 |
| Ryan, JF | 2 |
| Gullotta, F | 2 |
| Helpap, B | 2 |
| Harrison, GG | 3 |
| Greenfield, S | 1 |
| Bronsther, B | 1 |
| Abrams, MW | 1 |
| Chapman, CJ | 1 |
| Yazaki, S | 1 |
| Suziki, H | 1 |
| Ogawa, S | 1 |
| Kuniyoshi, K | 1 |
| Tai, K | 1 |
| Menzel, H | 1 |
| Freiberger, K | 1 |
| Zinganell, K | 1 |
| Sajons, M | 1 |
| Hammami, G | 1 |
| Sonnenklar, N | 1 |
| Krasna, IH | 1 |
| Skakun, NP | 1 |
| Oleĭnik, AN | 1 |
| Shendevitskiĭ, VI | 1 |
| Reske-Nielsen, E | 2 |
| Haase, J | 2 |
| Carballo, AS | 1 |
| Bergman, JA | 1 |
| Peltz, B | 1 |
| Carstens, J | 1 |
| Stephen, CR | 1 |
| Böttger, P | 1 |
| Doehn, M | 1 |
| Horatz, K | 1 |
| Kessler, G | 1 |
| Lovell, R | 1 |
| Tait, A | 1 |
| White, YS | 1 |
| Bloom, DA | 1 |
| Fonkalsrud, EW | 1 |
| Reynolds, RC | 1 |
| Csongrady, A | 1 |
| Bake, I | 1 |
| Pfänder, C | 1 |
| Tarmann, H | 1 |
| Schneider, M | 1 |
| Buttazzoni, E | 1 |
| Bendall, JR | 1 |
| Bakshi, KK | 1 |
| Cosgrove, SB | 1 |
| Martucci, RW | 1 |
| Schwid, HA | 1 |
| O'Donnell, D | 1 |
| Schneider, V | 1 |
| Eyrich, K | 1 |
| Stelzner, J | 1 |
| Haas, DA | 1 |
| Young, ER | 1 |
| Harper, DG | 1 |
| Kosko, JR | 1 |
| Chan, KH | 1 |
| Jantzen, JP | 1 |
| Eberle, B | 1 |
| Gaida, BJ | 1 |
| Hennes, HJ | 1 |
| Otto, S | 1 |
| Schäfer, M | 1 |
| Beech, J | 2 |
| Hon, CA | 1 |
| Landers, DF | 1 |
| Platts, AA | 1 |
| Broekema, AA | 1 |
| Boersma, GA | 1 |
| Hennis, PJ | 1 |
| Saddler, JM | 1 |
| Scholz, J | 1 |
| Rum, U | 1 |
| Schmitz, W | 1 |
| Scholz, H | 1 |
| Littleford, JA | 1 |
| Patel, LR | 1 |
| Bose, D | 1 |
| Cameron, CB | 1 |
| McKillop, C | 1 |
| Mehler, J | 1 |
| Bachour, H | 1 |
| Simons, F | 1 |
| Wolpers, K | 1 |
| Lazarus, A | 1 |
| Tripolitis, L | 1 |
| Erwin, K | 1 |
| Hanson, S | 1 |
| Conti, PA | 1 |
| Huggins, FJ | 1 |
| Sinclair, G | 1 |
| Aitken, HA | 1 |
| Howie, JC | 1 |
| Fay, RS | 1 |
| Guerreiro, JF | 1 |
| Santos, SE | 1 |
| Aguiar, GF | 1 |
| Jönsson, L | 2 |
| Häggendal, J | 2 |
| Johansson, G | 2 |
| Thorén-Tolling, K | 1 |
| Bjurström, S | 2 |
| Carlsten, J | 2 |
| Cornet, C | 1 |
| Moeller, R | 1 |
| Laxenaire, MC | 2 |
| Lienhart, A | 2 |
| Krivosic-Horber, R | 4 |
| Birmingham, PK | 1 |
| Stevenson, GW | 1 |
| Uejima, T | 1 |
| Hall, SC | 1 |
| Wilhoit, RD | 1 |
| Brown, RE | 1 |
| Bauman, LA | 1 |
| Ording, H | 4 |
| Lizzo, FH | 2 |
| Foster, PS | 1 |
| Hopkinson, KC | 1 |
| Ong, RO | 1 |
| Roggow, BD | 1 |
| Donaldson, SK | 1 |
| Louis, CF | 1 |
| Rempel, WE | 2 |
| Addonizio, G | 2 |
| Susman, VL | 1 |
| Hald, A | 1 |
| Sjøntoft, E | 1 |
| Smith, BE | 1 |
| Wackym, PA | 1 |
| Dubrow, TJ | 1 |
| Abdul-Rasool, IH | 1 |
| Lesavoy, MA | 1 |
| Jacquot, C | 1 |
| Stieglitz, P | 1 |
| Kozak-Reiss, G | 1 |
| Nivoche, Y | 1 |
| Nossaman, BD | 1 |
| Mata, JA | 1 |
| Geiduschek, J | 1 |
| Cohen, SA | 1 |
| Khan, A | 1 |
| Cullen, BF | 1 |
| Martino, C | 1 |
| Fletcher, J | 1 |
| Tahmoush, A | 1 |
| Yacoub, OF | 1 |
| Morrow, DH | 1 |
| Larach, DR | 1 |
| Broennle, AM | 1 |
| Tolpin, EI | 1 |
| Michaux, K | 1 |
| Skovgaard, LT | 1 |
| Friedman, AH | 1 |
| Skoog, SJ | 1 |
| Belman, AB | 1 |
| Wang, JM | 1 |
| Stanley, TH | 1 |
| Theunynck, D | 2 |
| Krivosic, I | 1 |
| Guévart, E | 1 |
| Steenson, AJ | 1 |
| Torkelson, RD | 1 |
| Wang, JJ | 1 |
| Lee, JC | 1 |
| Tzeng, JI | 1 |
| Chan, JH | 1 |
| Liu, SE | 1 |
| Lee, TY | 1 |
| Michel, PA | 1 |
| Fronefield, HP | 1 |
| Susman, V | 1 |
| Galloway, GJ | 1 |
| Braude, BM | 1 |
| Press, P | 1 |
| Moyes, DG | 1 |
| Isaacs, H | 1 |
| Danilewitz, MD | 1 |
| Kolb, ME | 1 |
| VanDerSpek, AF | 1 |
| Wilton, N | 1 |
| Foldes, FF | 1 |
| Smith, CL | 1 |
| Bush, GH | 1 |
| Riedesel, DH | 1 |
| López, JR | 1 |
| Alamo, LA | 1 |
| Jones, D | 1 |
| Papp, L | 1 |
| Allen, P | 1 |
| Gergely, J | 1 |
| Streter, F | 1 |
| Kelstrup, J | 1 |
| Jorni, J | 1 |
| Hanel, HK | 1 |
| Garstka, J | 1 |
| Wierusz, L | 1 |
| Kaukinen, S | 1 |
| Stenberg, J | 1 |
| Kaukinen, L | 1 |
| Caseby, NG | 1 |
| Kacinec, J | 1 |
| Malatinský, J | 1 |
| Sadlon, P | 1 |
| Klimasová, A | 1 |
| Purschke, R | 1 |
| Zindler, M | 1 |
| Newson, AJ | 1 |
| Sordill, W | 1 |
| Ladner, W | 1 |
| Stern, M | 1 |
| Weisenberg, M | 1 |
| Popinigis, J | 1 |
| Brucker, RF | 1 |
| Taylor, CA | 1 |
| Williams, CH | 1 |
| Dilworth, NM | 1 |
| Beasley, H | 1 |
| Rosalki, SB | 1 |
| Pembrey, ME | 1 |
| Ratzlaff, EH | 1 |
| Jenkins, LC | 1 |
| Iuchi, Y | 1 |
| Madono, K | 1 |
| Yamamoto, T | 1 |
| Yoshizumi, M | 1 |
| Ono, T | 1 |
| Wedley, JR | 1 |
| Jaffe, EC | 1 |
| Ehehalt, V | 1 |
| Burmeister, G | 1 |
| Sauer, H | 1 |
| Kerr, WS | 1 |
| King, JO | 1 |
| Takahashi, T | 1 |
| Takasaki, M | 1 |
| Namiki, A | 1 |
| Dohi, S | 1 |
| Rizk, SF | 1 |
| Bradley, WG | 1 |
| Bull, AB | 1 |
| Althoff, H | 1 |
| Harriman, DG | 2 |
| Sumner, DW | 2 |
| Brebner, J | 1 |
| Jozefowicz, JA | 1 |
| Jones, EW | 1 |
| Henrickson, RL | 1 |
| Falk, SN | 1 |
| Kerr, DD | 1 |
| Pöntinen, PJ | 1 |
| Abele, K | 1 |
| Autere, T | 1 |
| Keaney, NP | 1 |
| Kyei-Mensah, K | 1 |
| Tyrrell, JH | 1 |
| Hargreaves, JB | 1 |
| Parikh, RK | 1 |
| Mulrooney, PL | 1 |
| Harpman, JA | 1 |
45 reviews available for succinylcholine and Anesthesia Related Hyperthermia
| Article | Year |
|---|---|
Age-Specific Clinical Features of Pediatric Malignant Hyperthermia: A Review of 187 Cases Over 60 Years in Japan.
Topics: Age Factors; Child; Humans; Japan; Malignant Hyperthermia; Masseter Muscle; Middle Aged; Muscle Rigi | 2022 |
Anesthetic Management of the Patient with Mitochondrial Disease: A Review of Current Best Evidence.
Topics: Anesthesia; Anesthetics, General; Humans; Malignant Hyperthermia; Mitochondrial Diseases; Succinylch | 2022 |
Malignant hyperthermia in maxillofacial surgery: Literature review supported by case presentation.
Topics: Adolescent; Adult; Child; Dantrolene; Humans; Hyperthermia, Induced; Male; Malignant Hyperthermia; M | 2023 |
Postoperative weakness and anesthetic-associated rhabdomyolysis in a pediatric patient: a case report and review of the literature.
Topics: Albuterol; Anesthetics; Australia; Child; Female; Humans; Malignant Hyperthermia; Myalgia; Postopera | 2022 |
Personalized pediatric anesthesia and pain management: problem-based review.
Topics: Anesthesia; Anesthesiology; Apnea; Child; Child, Preschool; Humans; Malignant Hyperthermia; Pain; Pa | 2020 |
Malignant Hyperthermia-Associated Rhabdomyolysis After Succinylcholine: A Case Report.
Topics: Humans; Hyperthermia; Malignant Hyperthermia; Rhabdomyolysis; Succinylcholine | 2021 |
Anesthetic consideration for neuromuscular diseases.
Topics: Anesthesia; Anesthetics; gamma-Cyclodextrins; Heart Arrest; Humans; Hyperkalemia; Intraoperative Com | 2017 |
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for the Use of Potent Volatile Anesthetic Agents and Succinylcholine in the Context of RYR1 or CACNA1S Genotypes.
Topics: Anesthetics, Inhalation; Calcium Channels, L-Type; Genotype; Humans; Malignant Hyperthermia; Neuromu | 2019 |
Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic Review.
Topics: Dantrolene; Databases, Factual; Humans; Malignant Hyperthermia; Muscle Relaxants, Central; Neuromusc | 2019 |
Unexpected MH deaths without exposure to inhalation anesthetics in pediatric patients.
Topics: Anesthesia, General; Anesthetics, Inhalation; Child; Child, Preschool; Genotype; Halothane; Humans; | 2013 |
PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamics.
Topics: Apnea; Butyrylcholinesterase; Calcium Channels; Calcium Channels, L-Type; Humans; Hyperkalemia; Mali | 2015 |
Malignant hyperthermia and muscular dystrophies.
Topics: Adolescent; Anesthesia; Anesthetics, Inhalation; Child; Child, Preschool; Evidence-Based Medicine; F | 2009 |
Malignant hyperthermia: pharmacology of triggering.
Topics: Anesthetics, Inhalation; Animals; Dose-Response Relationship, Drug; Humans; Malignant Hyperthermia; | 2011 |
[Malignant hyperthermia].
Topics: Anesthesia, General; Dantrolene; Diagnosis, Differential; Genetic Predisposition to Disease; Humans; | 2002 |
[Malignant hyperthermia].
Topics: Anesthetics, Inhalation; Dantrolene; Diagnosis, Differential; Genetic Predisposition to Disease; Hum | 2003 |
Concepts in the prevention and management of malignant hyperthermia.
Topics: Humans; Malignant Hyperthermia; Neuromuscular Depolarizing Agents; Succinylcholine | 2003 |
Malignant hyperthermia.
Topics: Adolescent; Adult; Aged; Animals; Child; Child, Preschool; Diagnosis, Differential; Female; Genetic | 2007 |
Neuromuscular and mitochondrial disorders: what is relevant to the anaesthesiologist?
Topics: Anesthesiology; Anesthetics, Inhalation; Anesthetics, Intravenous; Humans; Hyperkalemia; Malignant H | 2008 |
The response of patients with neuromuscular disorders to muscle relaxants: a review.
Topics: Amyotrophic Lateral Sclerosis; Curare; Hemiplegia; Humans; Hyperkalemia; Malignant Hyperthermia; Mul | 1984 |
Cholinesterase and succinylcholine.
Topics: Cholinesterase Inhibitors; Cholinesterases; Genetic Variation; Genotype; Humans; Malignant Hyperther | 1983 |
Malignant hyperthermia.
Topics: Adult; Arrhythmias, Cardiac; Biopsy; Calcium; Child; Child, Preschool; Creatine Kinase; Dantrolene; | 1983 |
[Malignant hyperthermia, syndrome malin, and heat stroke].
Topics: Adolescent; Adult; Anesthesia, Inhalation; Animals; Calcium; Creatine Kinase; Halothane; Heat Exhaus | 1983 |
Genetic predisposition to environmental factors.
Topics: Drug-Related Side Effects and Adverse Reactions; Environment; Genes, MHC Class II; Genetic Linkage; | 1983 |
Porcine stress syndromes.
Topics: Animals; Disease Models, Animal; Drug Resistance; General Adaptation Syndrome; Glycolysis; Halothane | 1982 |
Malignant hyperthermia--pearls out of swine?
Topics: Animals; Body Temperature; Dantrolene; Disease Models, Animal; Halothane; Magnesium Sulfate; Maligna | 1980 |
Plasma cholinesterase variants and the anaesthetist.
Topics: Adult; Anesthesia; Apnea; Cholinesterases; Female; Gene Frequency; Genes; Genetic Variation; Genotyp | 1980 |
An update on the malignant hyperthermia syndrome.
Topics: Anesthetics; Animals; Calcium; Calcium Channels; Child; Dantrolene; Disease Models, Animal; Disease | 1994 |
Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.
Topics: Arrhythmias, Cardiac; Drug Labeling; Humans; Hyperkalemia; Incidence; Intraocular Pressure; Malignan | 1994 |
Malignant hyperpyrexia in oral surgery--case report and literature review.
Topics: Adult; Anesthesia, Dental; Anesthesia, Inhalation; Cyanosis; Female; Humans; Intraoperative Complica | 1994 |
Variants of malignant hyperthermia. Special problems for the paediatric anaesthesiologist.
Topics: Child; Child, Preschool; Death, Sudden, Cardiac; Female; Humans; Infant; Male; Malignant Hyperthermi | 1996 |
[Severe side-effects of curare-like agents in children].
Topics: Child; Heart Arrest; Humans; Malignant Hyperthermia; Masseter Muscle; Neuromuscular Blocking Agents; | 2000 |
Treatment of porcine malignant hyperthermia. A review based on experimental studies.
Topics: Animals; Blood Glucose; Body Temperature; Carbon Dioxide; Catecholamines; Chlorpromazine; Dantrolene | 1975 |
Anaesthesia of pigs sensitive to malignant hyperthermia.
Topics: Anesthesia; Animals; Barbiturates; Body Temperature; Cardiac Output; Dantrolene; Halothane; Heart Ra | 1977 |
Recent advances in pediatric anesthesia.
Topics: Ambulatory Care; Anesthesia; Anesthetics; Body Temperature Regulation; Child; Ethane; Halogens; Huma | 1976 |
Malignant hyperthermia and the general dentist: current recommendations.
Topics: Anesthesia, Dental; Anesthesia, General; Anesthetics; Calcium Metabolism Disorders; Cardiac Glycosid | 1992 |
[Clinical features of malignant hyperthermia crisis].
Topics: Adolescent; Adult; Anesthesia, General; Arrhythmias, Cardiac; Carbon Dioxide; Child; Child, Preschoo | 1989 |
[Anesthesia in myotonia].
Topics: Anesthesia; Contracture; Disease Susceptibility; Female; Humans; Hypercapnia; Male; Malignant Hypert | 1989 |
[Screening tests for malignant hyperthermia susceptibility].
Topics: Animals; Caffeine; Calcium; Cholinesterases; Contracture; Creatine Kinase; Cyclic AMP; Disease Susce | 1989 |
Pathophysiology of malignant hyperthermia.
Topics: Animals; Calcium; Creatine Kinase; Dantrolene; Disease Susceptibility; Halothane; Humans; Lymphocyte | 1989 |
Clinical presentation of malignant hyperthermia.
Topics: Adolescent; Adult; Animals; Child; Child, Preschool; Diagnosis, Differential; Humans; Malignant Hype | 1988 |
Malignant hyperthermia and ECT.
Topics: Adult; Anesthetics; Child; Electroconvulsive Therapy; Humans; Malignant Hyperthermia; Succinylcholin | 1986 |
[Malignant hyperthermia].
Topics: Age Factors; Alanine Transaminase; Anesthesia; Aspartate Aminotransferases; Carbon Dioxide; Halothan | 1972 |
The importance of changes in body temperature in paediatric surgery and anaesthesia.
Topics: Anesthesia; Blood Transfusion; Body Temperature; Body Temperature Regulation; Child; Exchange Transf | 1973 |
Uses and limitations of enzyme tests.
Topics: Alcoholism; Apnea; Child; Clinical Enzyme Tests; Diagnosis, Differential; Female; Hepatitis A; Heter | 1974 |
Pharmacogenetics.
Topics: Acetyltransferases; Administration, Topical; Alleles; Analgesics; Anemia, Hemolytic; Anti-Inflammato | 1974 |
1 trial available for succinylcholine and Anesthesia Related Hyperthermia
| Article | Year |
|---|---|
Identification of susceptibility to malignant hyperpyrexia.
Topics: Adolescent; Adult; Aged; Biopsy; Caffeine; Creatine Kinase; Drug Hypersensitivity; Electrocardiograp | 1974 |
265 other studies available for succinylcholine and Anesthesia Related Hyperthermia
| Article | Year |
|---|---|
Spinal cord injury-related thermoregulatory impairment masks a fatal malignant hyperthermia crisis: a case report.
Topics: Adult; Anesthetics; Humans; Isoflurane; Male; Malignant Hyperthermia; Ryanodine Receptor Calcium Rel | 2022 |
Malignant hyperthermia in Mazovia Province - are we adequately prepared?
Topics: Anesthetics, Inhalation; Dantrolene; Humans; Malignant Hyperthermia; Operating Rooms; Succinylcholin | 2022 |
Pre-operative exercise and pyrexia as modifying factors in malignant hyperthermia (MH).
Topics: Fever; Humans; Malignant Hyperthermia; Mutation; Preoperative Exercise; Ryanodine Receptor Calcium R | 2022 |
Succinylcholine, malignant hyperthermia and rhabdomyolysis.
Topics: Humans; Malignant Hyperthermia; Rhabdomyolysis; Succinylcholine | 2022 |
Impact of a digital manual for guidance on malignant hyperthermia: patient education.
Topics: Humans; Malignant Hyperthermia; Patient Education as Topic; Quality of Life; Succinylcholine | 2022 |
A Case Report of an Incidental Ultrasound Finding in a Suspected Malignant Hyperthermia Patient.
Topics: Anesthetics, Inhalation; Dantrolene; Female; Halothane; Humans; Malignant Hyperthermia; Middle Aged; | 2022 |
Succinylcholine Use and Dantrolene Availability: Reply.
Topics: Anesthesia; Dantrolene; Humans; Malignant Hyperthermia; Neuromuscular Depolarizing Agents; Succinylc | 2019 |
[Malignant Hyperthermia - Update on Pathophysiology, Diagnostics and Treatment].
Topics: Anesthetics, Inhalation; Dantrolene; Humans; Malignant Hyperthermia; Succinylcholine | 2019 |
[Pharmacological Treatment of Malignant Hyperthermia: Update 2019].
Topics: Anesthetics; Dantrolene; Humans; Malignant Hyperthermia; Neuromuscular Depolarizing Agents; Succinyl | 2019 |
A Chronology for the Identification and Disclosure of Adverse Effects of Succinylcholine.
Topics: Animals; Drug Approval; Drug Development; Drug Industry; History, 20th Century; Humans; Hyperkalemia | 2019 |
Malignant hyperthermia susceptibility: utilization of genetic results in an electronic medical record to increase safety.
Topics: Anesthetics, Inhalation; Calcium Channels, L-Type; Decision Support Systems, Clinical; Electronic He | 2020 |
Malignant hyperthermia in a 16-day-old infant with congenital diaphragmatic hernia: a case report.
Topics: Child; Dantrolene; Hernias, Diaphragmatic, Congenital; Humans; Hyperthermia; Infant; Malignant Hyper | 2021 |
Prevalence of malignant hyperthermia diagnosis in hospital discharge records in California, Florida, New York, and Wisconsin.
Topics: Adolescent; Adult; Aged; Anesthetics, Inhalation; California; Databases, Factual; Female; Florida; H | 2017 |
Malignant Hyperthermia and Ryanodine Receptor Type 1 Gene (RyR1) Mutation in a Family in Singapore.
Topics: Adult; Dantrolene; Female; Genetic Predisposition to Disease; Humans; Male; Malignant Hyperthermia; | 2017 |
[Abortive course of malignant hyperthermia following preclinical induction of general anesthesia using succinylcholine].
Topics: Anesthesia, General; Anesthetics, Intravenous; Dantrolene; Female; Fentanyl; Humans; Malignant Hyper | 2018 |
Succinylcholine and Dantrolene: Inseparable in the Emergency Cupboard?
Topics: Anesthesia; Dantrolene; Humans; Malignant Hyperthermia; Succinylcholine | 2019 |
The importance of a prepared and ready malignant hyperthermia response team.
Topics: Dantrolene; Female; Hospital Rapid Response Team; Humans; Intubation, Intratracheal; Malignant Hyper | 2019 |
Consensus Statement of the Malignant Hyperthermia Association of the United States on Unresolved Clinical Questions Concerning the Management of Patients With Malignant Hyperthermia.
Topics: Consensus; Dantrolene; Drug Administration Schedule; Evidence-Based Medicine; Exercise; Humans; Mali | 2019 |
Unexpected complications during anesthesia.
Topics: Adolescent; Anaphylaxis; Anesthesia; Anesthetics; Animals; Child; Chloroform; Drug Hypersensitivity; | 2014 |
[Helsinki Declaration on Patient Safety in Anaesthesiology - Part 3: SOP for malignant hyperthermia].
Topics: Anesthesia, General; Anesthetics; Diagnosis, Differential; Humans; Malignant Hyperthermia; Neuromusc | 2013 |
Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands.
Topics: Adolescent; Adult; Aged; Anesthetics; Caffeine; Canada; Child; Child, Preschool; Dantrolene; Female; | 2014 |
Functional and genetic characterization of clinical malignant hyperthermia crises: a multi-centre study.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Humans; Infant; Male; Malignant Hyperthermia; Mi | 2014 |
Anesthetic drugs and onset of malignant hyperthermia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthetics; Anesthetics, Inhalation; Child; Child, Pres | 2014 |
The effect of succinylcholine on malignant hyperthermia events in susceptible swine.
Topics: Animals; Blood Gas Analysis; Blood Gas Monitoring, Transcutaneous; Halothane; Hemodynamics; Malignan | 2014 |
An unusual case of malignant hyperthermia presenting on the acute medical take.
Topics: Emergency Service, Hospital; Humans; Male; Malignant Hyperthermia; Middle Aged; Neuromuscular Depola | 2015 |
The changing face of malignant hyperthermia: less fulminant, more insidious..
Topics: Adolescent; Aged; Anesthesia; Anesthetics, Inhalation; Creatine Kinase; Humans; Hypercapnia; Male; M | 2015 |
Succinylcholine for Emergency Airway Rescue in Class B Ambulatory Facilities: The Society for Ambulatory Anesthesia Position Statement.
Topics: Airway Management; Ambulatory Care; Ambulatory Care Facilities; Anesthesia; Dantrolene; Emergency Me | 2017 |
Suspected Malignant Hyperthermia in the Setting of Hypothermic Circulatory Arrest for Type A Aortic Dissection Repair: A Case Report.
Topics: Aortic Aneurysm; Aortic Dissection; Cardiopulmonary Bypass; Circulatory Arrest, Deep Hypothermia Ind | 2017 |
JSA guideline for the management of malignant hyperthermia crisis 2016.
Topics: Acidosis; Anesthetics, Inhalation; Body Temperature; Calcium; Carbon Dioxide; Dantrolene; Humans; Hy | 2017 |
Duchenne muscular dystrophy: Which is the best anesthetic agent?
Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Child; Humans; Intraoperative Complications; Mali | 2008 |
Pharmacogenomics and perioperative medicine--implications for modern clinical practice.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Analgesia, Obstetrical; Analgesics, Opioid; A | 2008 |
The place of suxamethonium in pediatric anesthesia.
Topics: Anesthesia; Child; Humans; Hyperkalemia; Malignant Hyperthermia; Masseter Muscle; Muscular Diseases; | 2009 |
Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation.
Topics: Amino Acid Substitution; Anesthetics, Inhalation; Arginine; Carnitine O-Palmitoyltransferase; Child, | 2009 |
General medicine and surgery for dental practitioners. Part 2--metabolic disorders.
Topics: Amyloidosis; Anesthetics, Local; Apnea; Carbohydrate Metabolism, Inborn Errors; Dental Care for Chro | 2010 |
Recognizing and treating malignant hyperthermia.
Topics: Dantrolene; Humans; Male; Malignant Hyperthermia; Muscle Relaxants, Central; Neuromuscular Depolariz | 2010 |
Ring fibers visualized by electron microscopy in a Japanese patient with malignant hyperthermia.
Topics: Anesthesia, General; Anesthetics, Inhalation; DNA Mutational Analysis; Humans; Isoflurane; Male; Mal | 2011 |
Magnesium does not influence the clinical course of succinylcholine-induced malignant hyperthermia.
Topics: Animals; Biomarkers; Carbon Dioxide; Disease Models, Animal; Energy Metabolism; Hemodynamics; Hydrog | 2011 |
Succinylcholine in malignant hyperthermia: evaluation of a novel in vivo model.
Topics: Animals; Disease Susceptibility; Female; Hemodynamics; Male; Malignant Hyperthermia; Muscle, Skeleta | 2011 |
Malignant hyperthermia and charcoal absorbent: too hot to handle.
Topics: Adsorption; Anesthesia; Anesthesia, Inhalation; Charcoal; Dantrolene; Filtration; Humans; Intraopera | 2011 |
The severity of sevoflurane-induced malignant hyperthermia.
Topics: Adolescent; Adult; Anesthesia, Inhalation; Anesthetics, Inhalation; Body Temperature; Child, Prescho | 2012 |
Estimate of the relative risk of succinylcholine for triggering malignant hyperthermia.
Topics: Adult; Algorithms; Anesthesia, Obstetrical; Anesthetics, Inhalation; Cohort Studies; Confidence Inte | 2013 |
Case report: Death in the emergency department: an unrecognized awake malignant hyperthermia-like reaction in a six-year-old.
Topics: Child; Diazepam; Emergency Medical Services; Emergency Service, Hospital; Fatal Outcome; Humans; Hyp | 2013 |
Case of leptosuccin induced malignant hyperthermia in a patient with GIST of the rectum.
Topics: Gastrointestinal Stromal Tumors; Humans; Male; Malignant Hyperthermia; Middle Aged; Neuromuscular De | 2012 |
No response to trigger agents in a malignant hyperthermia-susceptible patient.
Topics: Adult; Anesthetics, Inhalation; Body Temperature; Disease Susceptibility; Humans; Isoflurane; Male; | 2002 |
Suspected malignant hyperthermia reactions in New Zealand.
Topics: Adolescent; Adult; Anesthetics, Inhalation; Child; Child, Preschool; Female; Genetic Predisposition | 2002 |
Fatal malignant hyperthermia--delayed onset and atypical course.
Topics: Adult; Anesthetics, Inhalation; Autopsy; Fatal Outcome; Humans; Isoflurane; Male; Malignant Hyperthe | 2002 |
[Malignant hyperthermia during emergency craniotomy: a case report].
Topics: Acute Disease; Adolescent; Anesthesia, General; Carbon Dioxide; Craniotomy; Emergencies; Hematoma, E | 2003 |
[Masseter muscle rigidity after suxamethonium during induction and postoperative abortive malignant hyperthermia in a patient with esophageal achalasia].
Topics: Adult; Anesthesia, Epidural; Anesthesia, Intravenous; Dantrolene; Esophageal Achalasia; Humans; Infu | 2004 |
Volatile anesthetics and succinylcholine in cardiac ryanodine receptor defects.
Topics: Adolescent; Adult; Anesthesia, General; Anesthetics, Inhalation; Child; Child, Preschool; Female; He | 2004 |
Succinylcholine-induced masseter muscle rigidity during bronchoscopic removal of a tracheal foreign body.
Topics: Anesthesia, General; Bronchoscopy; Child, Preschool; Emergencies; Female; Foreign Bodies; Humans; Ma | 2005 |
Malignant hyperthermia: a case report in Thai Anesthesia Incidents Study (THAI Study).
Topics: Child, Preschool; Humans; Male; Malignant Hyperthermia; Neuromuscular Depolarizing Agents; Succinylc | 2005 |
The risk of malignant hyperthermia in children undergoing muscle biopsy for suspected neuromuscular disorder.
Topics: Adolescent; Adult; Anesthesia; Anesthetics, Inhalation; Biopsy; Child; Child, Preschool; Female; Hum | 2007 |
Molecular genetic testing to diagnose malignant hyperthermia susceptibility.
Topics: Child, Preschool; Genetic Testing; Humans; Laryngismus; Male; Malignant Hyperthermia; Neuromuscular | 2008 |
[Malignant hyperthermia: biochemico-metabolic aspects and personal experiences].
Topics: Adult; Dantrolene; Female; Halothane; Humans; Male; Malignant Hyperthermia; Succinylcholine | 1984 |
Malignant hyperthermia.
Topics: Acidosis; Bicarbonates; Calcium; Creatine Kinase; Dantrolene; Diuretics; Fever; Humans; Malignant Hy | 1982 |
[Contracture responses of the muscle from a patient with malignant hyperthermia to drugs].
Topics: Adolescent; Diltiazem; Enflurane; Halothane; Humans; In Vitro Techniques; Male; Malignant Hypertherm | 1984 |
Masseter spasm with anesthesia: incidence and implications.
Topics: Anesthetics; Child; Child, Preschool; Creatine Kinase; Halothane; Humans; Infant; Malignant Hyperthe | 1984 |
Electrodiagnostic tests in the detection of malignant hyperthermia.
Topics: Adolescent; Adult; Caffeine; Electric Stimulation; Electromyography; Evoked Potentials; Female; Halo | 1984 |
Malignant hyperthermia. A review and case report.
Topics: Adult; Anesthesia, Intravenous; Dantrolene; Humans; Male; Malignant Hyperthermia; Succinylcholine; T | 1983 |
Halothane and halothane/succinylcholine induced malignant hyperthermia (porcine stress syndrome) in a population of Ontario boars.
Topics: Animals; Disease Susceptibility; Drug Combinations; Halothane; Male; Malignant Hyperthermia; Ontario | 1983 |
Succinylcholine infusion associated with hyperthermia in ponies anesthetized with halothane.
Topics: Acidosis; Anesthesia, Endotracheal; Animals; Halothane; Horse Diseases; Horses; Malignant Hypertherm | 1983 |
Suxamethonium spasm. A differential diagnostic conundrum.
Topics: Diagnosis, Differential; Disease Susceptibility; Humans; Malignant Hyperthermia; Spasm; Succinylchol | 1984 |
Halothane-succinylcholine induced masseter spasm: indicative of malignant hyperthermia susceptibility?
Topics: Caffeine; Child; Child, Preschool; Creatine Kinase; Female; Halothane; Humans; Male; Malignant Hyper | 1984 |
Failure to induce malignant hyperthermia in myotonic goats.
Topics: Animals; Disease Susceptibility; Goats; Halothane; Malignant Hyperthermia; Myotonia Congenita; Succi | 1983 |
More on ECT and malignant hyperthermia.
Topics: Dantrolene; Electroconvulsive Therapy; Humans; Malignant Hyperthermia; Succinylcholine | 1983 |
[Atypical malignant hyperthermia].
Topics: Anesthesia, General; Child; Child, Preschool; Creatine Kinase; Female; Humans; Isoenzymes; L-Lactate | 1983 |
A protocol for malignant hyperthermia.
Topics: Anesthesia, Conduction; Anesthesia, Inhalation; Halothane; Humans; Malignant Hyperthermia; Succinylc | 1980 |
Mechanical properties of normal and malignant hyperthemia susceptible porcine muscle: effects of halothane and other drugs.
Topics: Animals; Anura; Caffeine; Drug Interactions; Epinephrine; Halothane; In Vitro Techniques; Male; Mali | 1980 |
Masseter spasm induced by succinylcholine in children: contracture testing for malignant hyperthermia: report of six cases.
Topics: Anesthesia; Caffeine; Child; Child, Preschool; Halothane; Humans; Male; Malignant Hyperthermia; Mass | 1982 |
Malignant hyperthermia: description and case report.
Topics: Adolescent; Anesthesia, Inhalation; Dantrolene; Humans; Male; Malignant Hyperthermia; Muscle Relaxan | 1982 |
Malignant hyperthermia.
Topics: Dantrolene; Humans; Lidocaine; Malignant Hyperthermia; Succinylcholine; Tachycardia | 1982 |
Isoflurane and malignant hyperthermia.
Topics: Adolescent; Humans; Isoflurane; Male; Malignant Hyperthermia; Methyl Ethers; Nitrous Oxide; Succinyl | 1982 |
[A case report of malignant hyperthermia (author's transl)].
Topics: Anesthesia, Intravenous; Child, Preschool; Halothane; Humans; Male; Malignant Hyperthermia; Succinyl | 1980 |
Suspected malignant hyperthermia in a strabismus patient. A case report.
Topics: Adolescent; Adult; Aged; Anesthesia, General; Child; Child, Preschool; Creatine Kinase; Esotropia; F | 1981 |
Rhabdomyolysis, myoglobinuria and hyperpyrexia caused by suxamethonium in a child with increased serum creatine kinase concentrations.
Topics: Anesthesia, Inhalation; Child, Preschool; Creatine Kinase; Female; Halothane; Humans; Male; Malignan | 1981 |
[Malignant hyperthermia. Intraoperative early diagnosis and indicating signs].
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Female; Humans; Male; Malignant Hyperthermi | 1981 |
Temperature dependence of muscle function in malignant hyperpyrexia-susceptible swine.
Topics: Animals; Caffeine; Halothane; In Vitro Techniques; Malignant Hyperthermia; Muscle Contraction; Potas | 1981 |
The chick as a model for malignant hyperpyrexia.
Topics: Animals; Calcium; Chickens; Dantrolene; Disease Models, Animal; Drug Evaluation, Preclinical; Malign | 1980 |
Dantrolene dose response in malignant hyperthermia-susceptible (MHS) swine: method to obtain prophylaxis and therapeusis.
Topics: Animals; Dantrolene; Dose-Response Relationship, Drug; Female; Hydrogen-Ion Concentration; Lactates; | 1980 |
[A case of malignant hyperpyrexia suggesting a gross muscle breakdown (author's transl)].
Topics: Adult; Anesthesia, General; Humans; Knee Injuries; Male; Malignant Hyperthermia; Muscle Rigidity; Mu | 1980 |
[Malignant hyperthermia. A case report (author's transl)].
Topics: Adolescent; Halothane; Heart Arrest; Hemorrhagic Disorders; Humans; Ice; Male; Malignant Hyperthermi | 1980 |
[Malignant hyperthermia. I. Observations in connection with its pathogenesis and course (author's transl)].
Topics: Anesthesia, General; Child, Preschool; Creatine Kinase; Electromyography; Female; Halothane; Humans; | 1980 |
Suxamethonium-induced jaw stiffness and myalgia associated with atypical cholinesterase: case report.
Topics: Anesthesia, General; Child; Cholinesterases; Humans; Jaw Diseases; Male; Malignant Hyperthermia; Mus | 1980 |
Modification of ryanodine toxicity by dantrolene and halothane in a model of malignant hyperthermia.
Topics: Alkaloids; Animals; Dantrolene; Diaphragm; Disease Models, Animal; Halothane; In Vitro Techniques; M | 1980 |
[Serum myoglobin levels following administration of succinylcholine during nitrous oxide-oxygen-halothane anesthesia (author's transl)].
Topics: Adolescent; Adult; Aged; Anesthesia, Inhalation; Child; Child, Preschool; Halothane; Humans; Maligna | 1980 |
Cardiovascular and metabolic responses to anesthetic-induced malignant hyperthermia in swine.
Topics: Animals; Coronary Circulation; Halothane; Hemodynamics; Malignant Hyperthermia; Muscle, Skeletal; My | 1995 |
Anesthetic complications in muscle disorders.
Topics: Anesthetics; Humans; Malignant Hyperthermia; Muscular Diseases; Myotonia; Succinylcholine | 1995 |
Masseter muscle rigidity associated with glycine1306-to-alanine mutation in the adult muscle sodium channel alpha-subunit gene.
Topics: Alanine; Base Sequence; Glycine; Humans; Malignant Hyperthermia; Masseter Muscle; Molecular Sequence | 1995 |
Anesthesia-induced rigidity, unrelated to succinylcholine, associated with Smith-Lemli-Opitz syndrome and malignant hyperthermia.
Topics: Abnormalities, Multiple; Anesthesia; Child, Preschool; Diagnosis, Differential; Halothane; Humans; M | 1995 |
Succinylcholine.
Topics: Adolescent; Atracurium; Child; Contraindications; Heart Arrest; Humans; Malignant Hyperthermia; Mass | 1994 |
Neuroleptic malignant syndrome and mivacurium: a safe alternative to succinylcholine?
Topics: Adult; Anesthesia, Intravenous; Bipolar Disorder; Creatine Kinase; Electroconvulsive Therapy; Female | 1994 |
Response to succinylcholine in porcine malignant hyperthermia.
Topics: Action Potentials; Afferent Pathways; Animals; Carbon Dioxide; Catecholamines; Electromyography; Fas | 1994 |
Should calcium be used to treat hyperkalemia after succinylcholine?
Topics: Calcium; Humans; Hyperkalemia; Malignant Hyperthermia; Resuscitation; Succinylcholine | 1994 |
The incidence of masseter muscle rigidity after succinylcholine in infants and children.
Topics: Anesthesia, Inhalation; Anesthesia, Intravenous; Child; Child, Preschool; Drug Interactions; Halotha | 1994 |
Postanaesthetic myoglobinuric renal failure: an isolated expression of malignant hyperthermia.
Topics: Acute Kidney Injury; Adult; Anesthesia; Enflurane; Hemorrhoids; Humans; Male; Malignant Hyperthermia | 1994 |
Management of lethal catatonia with dantrolene sodium.
Topics: Catatonia; Dantrolene; Electroconvulsive Therapy; Humans; Malignant Hyperthermia; Neuroleptic Malign | 1993 |
[A case of abortive malignant hyperthermia during funnel chest surgery].
Topics: Anesthesia, General; Child, Preschool; Ethers; Funnel Chest; Humans; Intraoperative Complications; M | 1993 |
Phenotypes associated with malignant hyperthermia susceptibility in swine genotyped as homozygous or heterozygous for the ryanodine receptor mutation.
Topics: Animals; Base Sequence; Calcium; Calcium Channels; Disease Susceptibility; Genotype; Halothane; Hete | 1993 |
[ENT anesthesia: the German Society of Anesthesia and Intensive Care Medicine on the use of succinylcholine].
Topics: Anesthesia, General; Child; Heart Arrest; Humans; Malignant Hyperthermia; Neuromuscular Depolarizing | 1995 |
Myotonias and masseter spasm: not malignant hyperthermia?
Topics: Animals; Goats; Humans; Malignant Hyperthermia; Masseter Muscle; Myotonia; Neuromuscular Depolarizin | 1995 |
[Mild variant of malignant hyperthermia following succinylcholine and halogenated agent exposure].
Topics: Anesthetics, Inhalation; Child; Humans; Isoflurane; Male; Malignant Hyperthermia; Neuromuscular Depo | 1995 |
Thermal response in acute porcine malignant hyperthermia.
Topics: Acute Disease; Animals; Body Temperature Regulation; Halothane; Malignant Hyperthermia; Muscles; Ski | 1996 |
Prior hypothermia attenuates malignant hyperthermia in susceptible swine.
Topics: Animals; Halothane; Hemodynamics; Hypothermia, Induced; Malignant Hyperthermia; Succinylcholine; Swi | 1996 |
Chlorocresol, an additive to commercial succinylcholine, induces contracture of human malignant hyperthermia-susceptible muscles via activation of the ryanodine receptor Ca2+ channel.
Topics: Animals; Caffeine; Calcium; Calcium Channels; Cresols; Dose-Response Relationship, Drug; Humans; In | 1996 |
[A case of malignant hyperthermia without hyperthermia].
Topics: Adolescent; Carbon Dioxide; Creatine Kinase; Dantrolene; Drug Eruptions; Fasciculation; Female; Huma | 1995 |
[Atypical malignant hyperthermia. A higher incidence than expected].
Topics: Anesthetics, Inhalation; Child, Preschool; Female; Flushing; Halothane; Humans; Incidence; Malignant | 1996 |
Masseter spasm and elevated creatine kinase after intravenous induction in a child.
Topics: Anesthesia, Intravenous; Child; Creatine Kinase; Humans; Male; Malignant Hyperthermia; Masseter Musc | 1996 |
Serum and urinary myoglobin following an aborted malignant hyperthermia reaction.
Topics: Adolescent; Creatine Kinase; Follow-Up Studies; Humans; Male; Malignant Hyperthermia; Myoglobin; Neu | 1996 |
Hyperkalemic cardiac arrest during anesthesia in infants and children with occult myopathies.
Topics: Adolescent; Anesthesia; Child; Child, Preschool; Confidence Intervals; Databases, Factual; Female; H | 1997 |
Malignant hyperthermia induced by general anesthesia for bone marrow harvesting.
Topics: Adult; Anesthetics, Inhalation; Bone Marrow; Bone Marrow Transplantation; Drug Synergism; Hematuria; | 1997 |
Antagonism of suxamethonium-induced jaw muscle contracture in rats.
Topics: Animals; Dantrolene; Male; Malignant Hyperthermia; Masseter Muscle; Muscle Relaxants, Central; Muscl | 1997 |
Succinylcholine-induced "masseter spasm".
Topics: Humans; Malignant Hyperthermia; Masseter Muscle; Neuromuscular Depolarizing Agents; Spasm; Succinylc | 1997 |
Evaluation for malignant hyperthermia susceptibility in black-tailed deer.
Topics: Anesthetics, Inhalation; Animals; Blood Gas Analysis; Cardiac Output; Deer; Disease Susceptibility; | 1996 |
Human malignant hyperthermia associated with desflurane anesthesia.
Topics: Adolescent; Adult; Aged; Anesthetics, Inhalation; Child; Child, Preschool; Dantrolene; Databases as | 1998 |
Suxamethonium, masseter spasm and later malignant hyperthermia.
Topics: Adult; Anesthetics, Inhalation; Humans; Isoflurane; Male; Malignant Hyperthermia; Masseter Muscle; N | 1998 |
Charcot-Marie-Tooth disease--suxamethonium and malignant hyperthermia triggering agents.
Topics: Charcot-Marie-Tooth Disease; Contraindications; Female; Humans; Malignant Hyperthermia; Neuromuscula | 1998 |
Malignant hyperthermia during desflurane-succinylcholine anesthesia for orthopedic surgery.
Topics: Adult; Anesthetics, Inhalation; Desflurane; Female; Humans; Isoflurane; Malignant Hyperthermia; Neur | 1999 |
Signs of an MH reaction.
Topics: Adjuvants, Anesthesia; Anesthetics, Inhalation; Atropine; Carbon Dioxide; Child; Fasciculation; Halo | 1999 |
Inhalation anesthetics and Duchenne's muscular dystrophy.
Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Contraindications; Disease Susceptibility; Haloth | 1999 |
Hemodynamic and metabolic manifestations of acute endotoxin infusion in pigs with and without the malignant hyperthermia mutation.
Topics: Animals; Calcium; Endotoxemia; Halothane; Hemodynamics; Malignant Hyperthermia; Mutation; Succinylch | 1999 |
Suxamethonium-induced rhabdomyolysis in a healthy middle-aged man.
Topics: Adult; Creatine Kinase; Humans; Male; Malignant Hyperthermia; Muscular Dystrophies; Neuromuscular De | 2000 |
Malignant hyperthermia phenotype: hypotension induced by succinylcholine in susceptible swine.
Topics: Animals; Blood Pressure; Cardiac Output; Femoral Artery; Heart; Hypotension; In Vitro Techniques; Ma | 2000 |
[An attack of malignant hyperthermia caused by a combination of the effects of succinylcholine, increased physical exertion and alcohol abuse].
Topics: Adult; Alcoholism; Humans; Male; Malignant Hyperthermia; Neuromuscular Depolarizing Agents; Physical | 1999 |
A case of intraoperative pyrexia.
Topics: Adolescent; Anesthesia, Inhalation; Diagnosis, Differential; Fracture Fixation; Humans; Intraoperati | 2000 |
Conquer difficult airways. Strategies to help you identify & control a problem airway.
Topics: Emergency Medical Services; Emergency Treatment; Humans; Hypnotics and Sedatives; Intubation, Intrat | 2001 |
Rapacuronium: an alternative to succinylcholine for electroconvulsive therapy.
Topics: Depressive Disorder; Disease Susceptibility; Electroconvulsive Therapy; Humans; Male; Malignant Hype | 2001 |
Malignant hyperthermia in a patient with Graves' disease during subtotal thyroidectomy.
Topics: Acidosis, Respiratory; Adult; Anesthetics; Antithyroid Agents; Carbon Dioxide; Creatine Kinase; Dant | 2001 |
Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1).
Topics: Amino Acid Sequence; Animals; Dog Diseases; Dogs; Female; Genotype; Halothane; In Vitro Techniques; | 2001 |
Porcine malignant hyperthermia induced by halothane and succinylcholine: failure of treatment with procaine or procainamide.
Topics: Animals; Catecholamines; Halothane; Hydrogen-Ion Concentration; Lactates; Malignant Hyperthermia; Po | 1976 |
Malignant hyperthermia.
Topics: Adult; Anesthesia, General; Humans; Male; Malignant Hyperthermia; Succinylcholine | 1976 |
Porcine malignant hyperthermia. III: Adrenergic blockade.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Glucose; Body Temperature; | 1976 |
Letter: Malignant hyperpyrexia.
Topics: Acidosis; Calcium; Catecholamines; Halothane; Humans; Insulin; Insulin Secretion; Malignant Hyperthe | 1975 |
[A case of malignant hyperthermia, in a child, induced by an anesthetic].
Topics: Child; Halothane; Humans; Hyalin; Male; Malignant Hyperthermia; Muscles; Succinylcholine | 1977 |
Identification of susceptibility to malignant hyperpyrexia in swine.
Topics: Animals; Caffeine; Disease Models, Animal; Dose-Response Relationship, Drug; Halothane; In Vitro Tec | 1979 |
A screening test for the malignant hyperpyrexia phenotype using suxamethonium-induced contracture of muscle treated with caffeine and its inhibition by dantrolene.
Topics: Adolescent; Adult; Caffeine; Child; Dantrolene; Drug Synergism; Humans; Malignant Hyperthermia; Midd | 1979 |
Malignant hyperthermia--the acute crisis.
Topics: Acid-Base Equilibrium; Acute Disease; Anesthesia, Intravenous; Arrhythmias, Cardiac; Electrolytes; H | 1979 |
Malignant hyperthermia: diagnosis, treatment and investigations of a skeletal muscle lesion.
Topics: Anesthetics; Animals; Caffeine; Diagnosis, Differential; Disease Models, Animal; Halothane; Humans; | 1979 |
The caffeine test of isolated human muscle in relation to malignant hyperthermia.
Topics: Adolescent; Adult; Caffeine; Child; Child, Preschool; Female; Humans; In Vitro Techniques; Male; Mal | 1977 |
Malignant hyperthermia in a Greyhound.
Topics: Anesthesia, Inhalation; Animals; Dog Diseases; Dogs; Halothane; Male; Malignant Hyperthermia; Succin | 1978 |
A case of rhabdomyolysis associated with suxamethonium.
Topics: Child; Diagnosis, Differential; Esophagoscopy; Humans; Male; Malignant Hyperthermia; Muscles; Muscul | 1978 |
[Malignant hyperthermia. Report on a case successfully treated by procaine infusion (author's transl)].
Topics: Adult; Female; Humans; Infusions, Parenteral; Malignant Hyperthermia; Muscle Rigidity; Pregnancy; Pr | 1978 |
[Histological, histochemical, and ultrastructural findings in malignant hyperthermia (author's transl)].
Topics: Adult; Autopsy; Cyanosis; Halothane; Histocytochemistry; Humans; Male; Malignant Hyperthermia; Micro | 1975 |
Porcine malignant hyperthermia: role of skeletal muscle in increased oxygen consumption.
Topics: Animals; Halothane; Malignant Hyperthermia; Muscles; Oxygen Consumption; Succinylcholine; Swine | 1977 |
The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine.
Topics: Administration, Oral; Anesthesia, General; Anesthesia, Inhalation; Animals; Dantrolene; Halothane; H | 1977 |
The malignant hyperthermia syndrome: an unusual complication of anesthesia.
Topics: Anesthesia, General; Appendectomy; Child; Halothane; Heart Arrest; Humans; Male; Malignant Hyperther | 1977 |
Drugs and genes: therapeutic implications.
Topics: Acetylation; Administration, Topical; Anemia, Hemolytic; Anti-Inflammatory Agents; Drug-Related Side | 1977 |
[Generalized muscular stiffness with myoglobinuria and increased serum enzymes induced by succinylcholine: a case report (author's transl)].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Child; Creatine Kinase; Humans; Male; Malignant H | 1977 |
Suxamethonium-induced porcine malignant hyperthermia.
Topics: Animals; Halothane; Lactates; Malignant Hyperthermia; Muscles; Oxygen Consumption; Succinylcholine; | 1976 |
[Report on 2 cases of malignant hyperthermia with different clinical courses].
Topics: Adult; Clinical Enzyme Tests; Creatine Kinase; Halothane; Humans; L-Lactate Dehydrogenase; Male; Mal | 1976 |
[Mild form of malignant hyperthermia? OR, ABNORMAL REACTION To succinyldicholine?].
Topics: Body Temperature; Child; Child, Preschool; Halothane; Humans; Malignant Hyperthermia; Neuroleptanalg | 1976 |
Clinical management of malignant hyperpyrexia.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Halothane; Heart Arrest; Humans; Male; Mal | 1976 |
[Adverse effect of muscle relaxants and narcotics in hereditary diseases (literature survey)].
Topics: Arrhythmias, Cardiac; Barbiturates; Butyrylcholinesterase; Drug Synergism; Drug Tolerance; Dysautono | 1976 |
Porcine malignant hyperthemia IV: Neuromuscular blockade.
Topics: Animals; Halothane; Malignant Hyperthermia; Neuromuscular Junction; Pancuronium; Succinylcholine; Sw | 1976 |
[Malignant hyperthermia].
Topics: Anesthesia, General; Anesthetics; Halothane; Humans; Male; Malignant Hyperthermia; Succinylcholine | 1975 |
Aborted malignant hyperthermia: case report.
Topics: Acidosis; Adult; Anesthesia, General; Aspartate Aminotransferases; Bicarbonates; Creatine Kinase; Fe | 1975 |
Idiopathic malignant hyperthermia. Review and report of a case.
Topics: Adolescent; Anesthesia, Inhalation; Brain Damage, Chronic; Chlorides; Heart Arrest; Humans; Male; Ma | 1975 |
An unusual case of malignant hyperpyrexia. First reported case in a South African negro.
Topics: Anesthesia, General; Black or African American; Black People; Body Temperature; Creatine Kinase; Hal | 1975 |
Editorial: Malignant hyperthermia.
Topics: Adult; Aged; Anesthesia, General; Anesthesia, Inhalation; Halothane; Humans; Infant; Malignant Hyper | 1975 |
[Malignant hyperthermia due to general anesthesia. Diagnosis and treatment].
Topics: Anesthesia, General; Anesthesia, Inhalation; Arrhythmias, Cardiac; Child, Preschool; Creatine Kinase | 1975 |
Proceedings: The metabolic course of porcine malignant hyperthermia.
Topics: Animals; Carbon Dioxide; Catecholamines; Halothane; Lactates; Malignant Hyperthermia; Potassium; Suc | 1975 |
Malignant hyperpyrexia during anesthesia in childhood.
Topics: Anesthesia, General; Child; Clinical Enzyme Tests; Creatine Kinase; Humans; Male; Malignant Hyperthe | 1976 |
[A further case of malignant hyperpyrexia and its treatment with lidocaine, methylprednisolone and verapamil (iproveratril) (author's transl)].
Topics: Acidosis; Adult; Calcium; Cryotherapy; Glucose; Halothane; Humans; Insulin; Lidocaine; Male; Maligna | 1976 |
Dantrolene in porcine malignant hyperthermia.
Topics: Animals; Dantrolene; Halothane; Hydantoins; Malignant Hyperthermia; Succinylcholine; Swine | 1976 |
Porcine malignant hyperthermia. I: Metabolic and physiological changes.
Topics: Animals; Blood Glucose; Body Temperature; Carbon Dioxide; Cardiac Output; Catecholamines; Fatty Acid | 1976 |
Porcine malignant hyperthermia. II: Heat production.
Topics: Animals; Body Temperature Regulation; Glucose; Halothane; Malignant Hyperthermia; Muscles; Oxygen Co | 1976 |
Rhabdomyolysis and acute renal failure following a single dose of succinylcholine.
Topics: Acute Kidney Injury; Diagnosis, Differential; Female; Humans; Malignant Hyperthermia; Rhabdomyolysis | 1992 |
Evaluation of greyhound susceptibility to malignant hyperthermia using halothane-succinylcholine anesthesia and caffeine-halothane muscle contractures.
Topics: Anesthesia, Inhalation; Animals; Caffeine; Disease Susceptibility; Dog Diseases; Dogs; Genetic Predi | 1992 |
Educational computer simulation of malignant hyperthermia.
Topics: Adult; Body Temperature; Computer Simulation; Dantrolene; Education, Medical; Female; Halothane; Hum | 1992 |
[Muscular dystrophy as a risk factor in anesthesia].
Topics: Anesthesia, General; Biopsy; Child; Humans; Infant; Male; Malignant Hyperthermia; Malpractice; Muscl | 1992 |
Masseter spasm and malignant hyperthermia: a retrospective review of a hospital-based pediatric otolaryngology practice.
Topics: Anesthesia, General; Child; Family Health; Halothane; Humans; Incidence; Malignant Hyperthermia; Mas | 1992 |
[The effect of muscle relaxants on masseter tone. An experimental study in an MH-susceptible swine model].
Topics: Anesthesia, Inhalation; Animals; Disease Susceptibility; Malignant Hyperthermia; Masseter Muscle; Sp | 1992 |
Interactions of fatty acids with the calcium release channel in malignant hyperthermia.
Topics: Animals; Caffeine; Calcium Channels; Fatty Acids; Halothane; Horses; Humans; Isoproterenol; Lipase; | 1991 |
Effects of neuroleptic agents on rat skeletal muscle contracture in vitro.
Topics: Animals; Antipsychotic Agents; Diaphragm; Droperidol; Drug Synergism; Haloperidol; Halothane; In Vit | 1991 |
A case of malignant hyperthermia?
Topics: Adult; Dantrolene; Humans; Isoflurane; Male; Malignant Hyperthermia; Muscles; Myoglobin; Succinylcho | 1991 |
Jaw stiffness--an ill understood condition.
Topics: Adult; Child; Humans; Intraoperative Complications; Jaw Diseases; Malignant Hyperthermia; Masseter M | 1991 |
Effects of caffeine, halothane, succinylcholine, phenylephrine and isoproterenol on myocardial force of contraction of malignant hyperthermia susceptible swine.
Topics: Animals; Caffeine; Disease Susceptibility; Halothane; Isoproterenol; Malignant Hyperthermia; Myocard | 1991 |
Masseter muscle spasm in children: implications of continuing the triggering anesthetic.
Topics: Anesthesia, Inhalation; Arrhythmias, Cardiac; Carbon Dioxide; Child; Child, Preschool; Creatine Kina | 1991 |
[Cardiac arrest during anesthesia induction with halothane and succinylcholine in an infant. Massive hyperkalemia and rhabdomyolysis in suspected myopathy and/or malignant hyperthermia].
Topics: Anesthesia, Inhalation; Cardiomyopathies; Halothane; Heart Arrest; Humans; Hyperkalemia; Infant; Mal | 1991 |
Malignant hyperthermia during ECT.
Topics: Adult; Electroconvulsive Therapy; Humans; Male; Malignant Hyperthermia; Psychotic Disorders; Succiny | 1991 |
Fatty acids modulate calcium-induced calcium release from skeletal muscle heavy sarcoplasmic reticulum fractions: implications for malignant hyperthermia.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Calcium; Chromatography, Gas; Fatty Acids; Halothane; | 1990 |
The importance of calcium ions for in vitro malignant hyperthermia testing.
Topics: Caffeine; Calcium; Contracture; Drug Interactions; Halothane; Humans; In Vitro Techniques; Malignant | 1990 |
Masseter spasm following suxamethonium.
Topics: Adult; Female; Humans; Malignant Hyperthermia; Masseter Muscle; Pregnancy; Pregnancy, Ectopic; Spasm | 1990 |
Possible malignant hyperpyrexia.
Topics: Anesthesia; Child; Disease Susceptibility; Humans; Male; Malignant Hyperthermia; Succinylcholine; Th | 1990 |
Halothane sensitivity of young pigs in vivo and in vitro.
Topics: Animals; Drug Hypersensitivity; Halothane; Malignant Hyperthermia; Muscle Contraction; Muscles; Succ | 1990 |
Serum cholinesterase polymorphism (CHE1 and CHE2 loci) among several Indian groups from Amazon region of Brazil, and segregation of the C5 variant in families.
Topics: Alleles; Brazil; Butyrylcholinesterase; Disease Susceptibility; Female; Gene Frequency; Genetic Vari | 1989 |
Cardiac manifestation and blood catecholamine levels during succinylcholine-induced stress of malignant hyperthermia sensitive pigs.
Topics: Animals; Catecholamines; Female; Heart; Male; Malignant Hyperthermia; Myocardium; Stress, Physiologi | 1989 |
Isolated postoperative myoglobinuria in a pediatric outpatient. A case report of malignant hyperthermia.
Topics: Ambulatory Surgical Procedures; Child; Gastroscopy; Humans; Male; Malignant Hyperthermia; Myoglobinu | 1989 |
Possible malignant hyperthermia in a 7-week-old infant.
Topics: Creatine Kinase; Halothane; Humans; Infant; Male; Malignant Hyperthermia; Muscular Dystrophies; Succ | 1989 |
Suxamethonium and malignant hyperthermia.
Topics: Humans; Malignant Hyperthermia; Succinylcholine | 1989 |
Effects of droperidol, haloperidol and ketamine on halothane, succinylcholine and caffeine contractures: implications for malignant hyperthermia.
Topics: Animals; Caffeine; Contracture; Droperidol; Haloperidol; Halothane; Humans; Ketamine; Male; Malignan | 1989 |
Effect of diltiazem on porcine malignant hyperpyrexia induced by suxamethonium and halothane.
Topics: Anesthesia; Animals; Blood Pressure; Diltiazem; Female; Halothane; Male; Malignant Hyperthermia; Suc | 1989 |
Malignant hyperthermia-like syndrome associated with metrizamide myelography.
Topics: Adult; Diagnosis, Differential; Humans; Injections, Spinal; Isoflurane; Male; Malignant Hyperthermia | 1989 |
Halothane-sensitivity gene and muscle contractile properties in malignant hyperthermia.
Topics: Animals; Genes; Genetic Carrier Screening; Halothane; Homozygote; Malignant Hyperthermia; Muscle Con | 1989 |
ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome.
Topics: Adolescent; Adult; Antipsychotic Agents; Arrhythmias, Cardiac; Bipolar Disorder; Catatonia; Diagnosi | 1987 |
Ketanserin and malignant hyperthermia in pigs.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Body Temperature; Carbon Dioxide; Halothane; Heart | 1986 |
Anesthetic emergencies.
Topics: Airway Obstruction; Anaphylaxis; Anesthesia; Anesthesia, Conduction; Anesthesia, Intravenous; Anesth | 1985 |
Malignant hyperthermia in plastic surgery.
Topics: Adult; Caffeine; Child; Child, Preschool; Dermoid Cyst; Disease Susceptibility; Facial Neoplasms; Fe | 1988 |
Disordered catecholamine release in pigs susceptible to malignant hyperthermia.
Topics: Animals; Catecholamines; Dantrolene; Female; Male; Malignant Hyperthermia; Stress, Physiological; Su | 1988 |
[Registration of peranesthetic cases of malignant hyperthermia in France. An update].
Topics: Adolescent; Adult; Anesthetics; Child; Child, Preschool; Dantrolene; Female; France; Humans; Infant; | 1988 |
Re: Anesthetic induction trismus, more than a closed mouth problem.
Topics: Anesthesia, Inhalation; Child, Preschool; Emergency Medical Tags; Halothane; Humans; Male; Malignant | 1988 |
Repeated anesthesia for a patient with neuroleptic malignant syndrome.
Topics: Adult; Anesthesia; Electroconvulsive Therapy; Humans; Male; Malignant Hyperthermia; Neuroleptic Mali | 1988 |
Malignant hyperthermia in myotonia congenita.
Topics: Adult; Anesthesia; Biopsy; Female; Halothane; Humans; Malignant Hyperthermia; Muscles; Myotonia Cong | 1988 |
Suxamethonium and MHS muscle.
Topics: Animals; Female; Humans; In Vitro Techniques; Male; Malignant Hyperthermia; Muscle Contraction; Succ | 1988 |
Role of electroconvulsive therapy in neuroleptic malignant syndrome (NMS)
Topics: Electroconvulsive Therapy; Humans; Malignant Hyperthermia; Neuroleptic Malignant Syndrome; Succinylc | 1987 |
Prediction of malignant hyperthermia susceptibility by clinical signs.
Topics: Adolescent; Anesthesia, General; Biopsy; Caffeine; Child; Halothane; Humans; Infant; Malignant Hyper | 1987 |
Effects of anaesthetic agents on erythrocyte fragility: comparison of normal and malignant hyperthermia susceptible patients.
Topics: Disease Susceptibility; Ethanol; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Osm | 1987 |
In vitro diagnosis of susceptibility to malignant hyperthermia: evaluation of tests with halothane-caffeine, potassium chloride, suxamethonium and caffeine-suxamethonium.
Topics: Caffeine; Disease Susceptibility; Evaluation Studies as Topic; Halothane; Humans; In Vitro Technique | 1987 |
Trismus is not trivial.
Topics: Child; Humans; Malignant Hyperthermia; Masseter Muscle; Muscle Rigidity; Succinylcholine; Trismus | 1987 |
Succinylcholine: a depolarizing relaxant.
Topics: Animals; Humans; Malignant Hyperthermia; Succinylcholine; Swine | 1987 |
Anesthetic induction trismus, more than a closed-mouth problem.
Topics: Anesthesia, Intravenous; Child; Female; Humans; Malignant Hyperthermia; Succinylcholine; Trismus | 1986 |
Duchenne muscular dystrophy and malignant hyperthermia--two case reports.
Topics: Anesthesia, Inhalation; Child, Preschool; Fentanyl; Halothane; Humans; Hyperkalemia; Infant; Male; M | 1986 |
[Examination of the family of a patient susceptible to anesthetic malignant hyperthermia].
Topics: Adolescent; Adult; Biopsy; Disease Susceptibility; Female; Halothane; Humans; Male; Malignant Hypert | 1986 |
In vitro muscle contractures induced by halothane and suxamethonium. II: Human skeletal muscle from normal and malignant hyperthermia susceptible patients.
Topics: Disease Susceptibility; Fatty Acids, Nonesterified; Halothane; Humans; In Vitro Techniques; Indometh | 1986 |
Evaluation of a commercial creatine kinase screening test for malignant hyperthermia (porcine stress syndrome).
Topics: Age Factors; Analysis of Variance; Animals; Clinical Enzyme Tests; Creatine Kinase; Halothane; Lumin | 1986 |
King's syndrome with malignant hyperthermia. Potential outpatient risks.
Topics: Abnormalities, Multiple; Adolescent; Anesthesia, General; Diseases in Twins; Facial Bones; Growth Di | 1987 |
[Hyperkalemia induced by succinylcholine injection in woman with metabolic acidosis].
Topics: Acidosis; Adult; Female; Humans; Hyperkalemia; Malignant Hyperthermia; Succinylcholine | 1986 |
[Postoperative hyperthermic syndrome with a questionable relationship to malignant hyperthermia and the need for elucidating susceptibility].
Topics: Anesthesia; Female; Halothane; Humans; Malignant Hyperthermia; Middle Aged; Postoperative Complicati | 1986 |
Use of atracurium in a patient susceptible to malignant hyperthermia.
Topics: Anesthesia, Inhalation; Atracurium; Child; Female; Humans; Isoquinolines; Malignant Hyperthermia; Mu | 1985 |
[Capnography and anesthetic-induced malignant hyperthermia].
Topics: Animals; Carbon Dioxide; Dantrolene; Halothane; Malignant Hyperthermia; Monitoring, Physiologic; Suc | 1985 |
Neuroleptic malignant syndrome and use of anesthetic agents.
Topics: Anesthetics; Halothane; Humans; Malignant Hyperthermia; Neuroleptic Malignant Syndrome; Succinylchol | 1986 |
Masseter muscle rigidity and malignant hyperthermia susceptibility.
Topics: Caffeine; Child; Creatine Kinase; Female; Halothane; Humans; Male; Malignant Hyperthermia; Masseter | 1986 |
Suxamethonium chloride and malignant hyperpyrexia.
Topics: Animals; Benzyl Alcohol; Benzyl Alcohols; Cresols; In Vitro Techniques; Malignant Hyperthermia; Musc | 1986 |
Unexpected hyperthermia manifesting during outpatient anesthesia.
Topics: Adolescent; Anesthesia, General; Colonoscopy; Halothane; Humans; Lymphangiectasis, Intestinal; Male; | 1986 |
More about masseter spasm and malignant hyperthermia.
Topics: Anesthesia; Child; Humans; Malignant Hyperthermia; Masseter Muscle; Muscle Rigidity; Spasm; Succinyl | 1985 |
Suxamethonium spasm.
Topics: Humans; Malignant Hyperthermia; Spasm; Succinylcholine | 1985 |
Verapamil is not a therapeutic adjunct to dantrolene in porcine malignant hyperthermia.
Topics: Anesthesia, Inhalation; Animals; Blood Gas Analysis; Blood Pressure; Dantrolene; Drug Synergism; Hal | 1985 |
Incidence of malignant hyperthermia in Denmark.
Topics: Adolescent; Adult; Aged; Anesthesia, Inhalation; Child; Child, Preschool; Denmark; Female; Humans; I | 1985 |
In vitro interaction between halothane and succinylcholine in human skeletal muscle: implications for malignant hyperthermia and masseter muscle rigidity.
Topics: Caffeine; Disease Susceptibility; Drug Interactions; Halothane; Humans; In Vitro Techniques; Maligna | 1985 |
Anaesthesia and progressive muscular dystrophy.
Topics: Adolescent; Adult; Anesthesia, General; Child; Child, Preschool; Heart Arrest; Humans; Male; Maligna | 1985 |
Unusual response following use of succinylcholine in a horse anesthetized with halothane.
Topics: Anesthesia, General; Animals; Female; Halothane; Horse Diseases; Horses; Malignant Hyperthermia; Mus | 1985 |
[Determination of intracellular free calcium concentration, in vivo, in swine susceptible to malignant hyperthermia syndrome].
Topics: Animals; Calcium; Dantrolene; Halothane; Malignant Hyperthermia; Membrane Potentials; Muscle Contrac | 1985 |
Drugs causing rigidity in malignant hyperthermia.
Topics: Atropine; Drug Synergism; Humans; Malignant Hyperthermia; Muscle Rigidity; Succinylcholine | 1973 |
Malignant hyperthermia in a family.
Topics: Adenosine Triphosphatases; Anesthesia, General; Barbiturates; Biopsy; Cell Membrane; Creatine Kinase | 1973 |
[Malignant hyperthermia syndrome].
Topics: Adolescent; Anesthetics; Female; Halothane; Humans; Malignant Hyperthermia; Scoliosis; Succinylcholi | 1974 |
A fatal case of malignant hyperthermia during anaesthesia and a study of the patient's blood relatives.
Topics: Adult; Anesthesia, General; Appendectomy; Creatine Kinase; Female; Humans; Isoenzymes; L-Lactate Deh | 1974 |
Letter: Myopathies and malignant hyperpyrexia.
Topics: Caffeine; Calcium; Humans; In Vitro Techniques; Malignant Hyperthermia; Muscle Contraction; Muscles; | 1974 |
Editorial: New causes of malignant hyperpyrexia.
Topics: Anesthetics; Dexamethasone; Halothane; Humans; Malignant Hyperthermia; Nitrous Oxide; Succinylcholin | 1974 |
Letter: Anaesthesia during raised creatine phosphokinase activity.
Topics: Anesthesia, General; Creatine Kinase; Humans; Malignant Hyperthermia; Muscles; Succinylcholine | 1974 |
[Syndrome of malignant hyperthermia].
Topics: Adolescent; Halothane; Humans; Male; Malignant Hyperthermia; Succinylcholine; Syndrome | 1974 |
[Malignant hyperthermia--clinical aspects and treatment of life-endangering complications of anesthesia].
Topics: Acidosis; Acute Kidney Injury; Anesthesia, General; Brain Edema; Calcium; Cell Membrane Permeability | 1974 |
Malignant hyperthermia: current trends in treatment.
Topics: Acidosis; Bicarbonates; Clinical Enzyme Tests; Creatine Kinase; Cryosurgery; Humans; Hyperkalemia; M | 1973 |
New Zealand Committee on Adverse Drug Reactions. Eighth annual report.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Aged; Anesthesia, Dental; Anesthesia, Local; Anti-Ba | 1973 |
Malignant hyperthermia.
Topics: Anesthesia, Intravenous; Child; Creatine Kinase; Female; Gastrointestinal Hemorrhage; Humans; Hypoxi | 1973 |
Hyperthermia associated with ophthalmic surgery.
Topics: Anesthesia, General; Blepharoptosis; Child; Child, Preschool; Female; Fever; Halothane; Humans; Infu | 1974 |
Malignant hyperthermia: a case report of successful management.
Topics: Anesthesia, Intravenous; Child; Humans; Male; Malignant Hyperthermia; Succinylcholine | 1972 |
[2 cases of malignant hyperpyrexia--with special reference to successful treatment by femoral VA bypass].
Topics: Adult; Anesthesia, General; Arteriovenous Shunt, Surgical; Femoral Artery; Femoral Vein; Halothane; | 1972 |
Pathology of malignant hyperpyrexia.
Topics: Anesthesia, General; Animals; Biopsy; Calcium; Creatine Kinase; Halothane; Humans; Malignant Hyperth | 1973 |
Malignant hyperpyrexia and the dental outpatient.
Topics: Adolescent; Adult; Anesthesia, Dental; Anesthesia, General; Child; Child, Preschool; Creatine Kinase | 1973 |
Thyroid status in malignant hyperpyrexia.
Topics: Animals; Halothane; Malignant Hyperthermia; Succinylcholine; Swine; Thyroid Hormones | 1973 |
[Anesthesia incident: malignant hyperthermia (case report)].
Topics: Alanine Transaminase; Anesthesia; Anesthesia, Inhalation; Anesthesia, Intravenous; Aspartate Aminotr | 1973 |
Malignant hyperthermia: a catastrophic complication.
Topics: Anesthesia, General; Bicarbonates; Cryotherapy; Halothane; Humans; Hyperkalemia; Insulin; Malignant | 1973 |
Malignant hyperpyrexia in Australia and New Zealand.
Topics: Adolescent; Adult; Anesthesia, General; Australia; Child; Child, Preschool; Creatine Kinase; Cryothe | 1973 |
Rise in serum creatine phosphokinase associated with agents used in anaesthesia.
Topics: Adolescent; Anesthesia, General; Anesthetics; Child; Child, Preschool; Creatine Kinase; Female; Halo | 1973 |
Malignant hyperpyrexia in a Negro.
Topics: Black or African American; Black People; Gallamine Triethiodide; Halothane; Humans; Male; Malignant | 1973 |
Malignant hyperpyrexia.
Topics: Ethyl Ethers; Halothane; Humans; Malignant Hyperthermia; Succinylcholine | 1973 |
Recent advances in the understanding of anaesthetic-induced malignant hyperpyrexia.
Topics: Acidosis; Anesthetics; Animals; Anura; Bicarbonates; Caffeine; Calcium; Cold Temperature; Disease Mo | 1973 |
[Limited anesthetic possibilities in patients with hereditary muscular diseases].
Topics: Aminosalicylic Acids; Anesthesia, General; Autopsy; Child; Child, Preschool; Death, Sudden; Fever; H | 1973 |
Althesin and malignant hyperpyrexia.
Topics: Anesthetics; Animals; Body Temperature; Drug Combinations; Halothane; Hydroxysteroids; Intubation, I | 1973 |
Malignant hyperpyrexia myopathy.
Topics: Adolescent; Adult; Anesthesia, General; Atrophy; Biopsy; Child; Child, Preschool; Female; Halothane; | 1973 |
Procainamide therapy of malignant hyperthermia: case report.
Topics: Adult; Anesthesia, Inhalation; Anesthesia, Intravenous; Atropine; Biopsy; Blood Pressure; Body Tempe | 1974 |
Porcine malignant hyperthermia: observations on the occurrence of pale, soft, exudative musculature among susceptible pigs.
Topics: Adenosine Triphosphate; Animals; Calcium; Creatine Kinase; Halothane; Hydrogen-Ion Concentration; La | 1974 |
Biochemical basis of malignant hyperpyrexia.
Topics: Biopsy; Caffeine; Calcium; Cell Membrane; Creatine Kinase; Extracellular Space; Halothane; Humans; I | 1974 |
[Malignant hyperthermia].
Topics: Anesthesia, Inhalation; Female; Halothane; Humans; Infant; Malignant Hyperthermia; Succinylcholine | 1974 |
Screening for malignant hyperpyrexia.
Topics: Acidosis; Adolescent; Adult; Anesthesia, General; Biopsy; Child; Child, Preschool; Creatine Kinase; | 1972 |
Anesthetic malignant myopathy hyperthermia.
Topics: Acidosis; Adolescent; Anesthesia, Inhalation; Autopsy; Brain Edema; Cold Temperature; Female; Haloth | 1972 |